Health Technology

From Frenzy Capital
Jump to navigation Jump to search

Symbol Name Rank Change Headline Date
OTIC Otonomy Inc 19.07 96.0784 U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.01% By Investing.com - Investing.com 11/29/2022, 16:25:00
OTIC Otonomy Inc 19.07 96.0784 Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday’s Mid-Day Sessio - Benzinga 11/29/2022, 11:47:48
OTIC Otonomy Inc 19.07 96.0784 Where Does Otonomy Inc (OTIC) Stock Fall in the Biotechnology Field After It Is Up 137.50% This Week? - InvestorsObserver 11/29/2022, 11:39:10
OTIC Otonomy Inc 19.07 96.0784 Thinking about buying stock in Nike, Otonomy, Wynn Resorts, Weibo, or Block? - Marketscreener.com 11/29/2022, 11:10:03
OTIC Otonomy Inc 19.07 96.0784 Syncona Limited Portfolio Company Extends Tender Offer to Acquire Applied Genetic Technologies Corporation - Marketscreener.com 11/29/2022, 08:01:46
ALC Alcon, Inc. 7.56 -0.8547 Glaucoma Pipeline Assessment 70+ Companies & 70+ Drugs DelveInsight - Digital Journal 11/29/2022, 16:16:47
ALC Alcon, Inc. 7.56 -0.8547 Eyewear Market to Grow by USD 76 Bn, Apparel, Accessories & Luxury Goods Industry Considered as Parent Market - Technavio - PR Newswire 11/29/2022, 11:00:00
ALC Alcon, Inc. 7.56 -0.8547 Laser Vision Correction Market Generated Opportunities, Future Scope 2022-2028 Johnson & Johnson., Alcon Laboratories, Inc., Nidek co., Ltd., Bausch Health Companies Inc - Digital Journal 11/29/2022, 05:55:12
ALC Alcon, Inc. 7.56 -0.8547 Myopia And Presbyopia Treatment Market to See Booming Growth 2022-2028 ALCON Inc., Bausch Health Companies Inc., EssilorLuxottica (Essilor Ltd.), Johnson & Johnson Vision - Digital Journal 11/29/2022, 05:54:46
ALC Alcon, Inc. 7.56 -0.8547 Ragweed Pollen Allergy Treatment Market Huge Growth in Future Scope 2022-2028 ALK-Abello A/S, ASIT Biotech SA, Anergis SA, Biomay AG, and Astellas Pharma Inc., Thermo Fisher Scientific Inc - Digital Journal 11/29/2022, 05:54:46
APEN Apollo Endosurgery Inc 7.21 67.8333 SHAREHOLDER ALERT: Weiss Law Investigates Apollo Endosurgery, Inc. - PR Newswire 11/29/2022, 17:10:00
APEN Apollo Endosurgery Inc 7.21 67.8333 U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.01% By Investing.com - Investing.com 11/29/2022, 16:25:00
APEN Apollo Endosurgery Inc 7.21 67.8333 BigCommerce, Chevron rise; Chemours, AMC Networks fall - The Seattle Times 11/29/2022, 16:19:06
APEN Apollo Endosurgery Inc 7.21 67.8333 Nasdaq Down 50 Points; Crude Oil Rises Over 1% - Apollo Endosurgery (NASDAQ:APEN), Bilibili (NASDAQ:BILI) - Benzinga 11/29/2022, 14:26:33
APEN Apollo Endosurgery Inc 7.21 67.8333 Healthcare Stocks Moving Tuesday: APEN, ONCS, VAXX, PALI, CNSP, CINC, NUTX, BEAT - InvestorsObserver 11/29/2022, 14:20:03
HZNP Horizon Therapeutics Plc 6.25 31.2821 Horizon Therapeutics fields buyout interest from Amgen, J&J and Sanofi - Reuters 11/29/2022, 18:12:00
HZNP Horizon Therapeutics Plc 6.25 31.2821 Other news to note for Nov. 29, 2022 - BioWorld Online 11/29/2022, 17:41:50
HZNP Horizon Therapeutics Plc 6.25 31.2821 UK to Relax Ring-Fencing of Banks as Part of Brexit ‘Big Bang’ - Yahoo Canada Finance 11/29/2022, 17:40:51
HZNP Horizon Therapeutics Plc 6.25 31.2821 Canadian Dollar Tumbles as Economic Data Show Signs of Slowdown - Yahoo Canada Finance 11/29/2022, 14:37:38
HZNP Horizon Therapeutics Plc 6.25 31.2821 AstraZeneca Takes Personalized Approach To Cell Therapy With Neogene Buy - Scrip 11/29/2022, 12:37:43
CRBP Corbus Pharmaceuticals Holdings Inc 4.71 42.0217 Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch 11/28/2022, 16:50:00
CRBP Corbus Pharmaceuticals Holdings Inc 4.71 42.0217 Why G Medical Innovations Shares Are Trading Lower By 35%; Here Are 25 Stocks Moving Premarket - Alset (N - Benzinga 11/21/2022, 07:45:08
CRBP Corbus Pharmaceuticals Holdings Inc 4.71 42.0217 Corbus Pharmaceuticals Holdings Inc. stock falls Thursday, underperforms market - MarketWatch 11/17/2022, 03:00:00
CRBP Corbus Pharmaceuticals Holdings Inc 4.71 42.0217 Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday’s Mid- - Benzinga 11/15/2022, 03:00:00
CRBP Corbus Pharmaceuticals Holdings Inc 4.71 42.0217 Why PlayAGS Shares Are Trading Lower By Over 15%; Here Are 33 Stocks Moving Premarket - BIMI Intl Medical - Benzinga 11/15/2022, 03:00:00
MRK Merck & Co Inc 3.36 0.332 Horizon Therapeutics in Separate Sale Talks With Amgen, Sanofi, J&J - Bloomberg 11/29/2022, 18:57:50
MRK Merck & Co Inc 3.36 0.332 Roche Withdraws Tecentriq's Frontline Bladder Cancer Indication, Ceding Market To Keytruda - Scrip 11/29/2022, 17:25:16
MRK Merck & Co Inc 3.36 0.332 Merck & Co. Inc. stock rises Tuesday, outperforms market - MarketWatch 11/29/2022, 17:20:00
MRK Merck & Co Inc 3.36 0.332 Portage Biotech Announces Results for Fiscal Quarter Ended September 30, 2022 - Yahoo Finance 11/29/2022, 16:43:00
MRK Merck & Co Inc 3.36 0.332 Gilead And Arcus' Latest Update Keeps TIGIT Hopes Afloat - Scrip 11/29/2022, 12:50:32
CPHI China Pharma Holdings Inc. 3.14 29.6362 Deal Watch: BMS Backs Out Of UniQure Gene Therapy Collaboration - Scrip 11/29/2022, 18:32:45
CPHI China Pharma Holdings Inc. 3.14 29.6362 Rgenta's $52M series A to bolster RNA small-molecule push - BioWorld Online 11/29/2022, 17:55:54
CPHI China Pharma Holdings Inc. 3.14 29.6362 Other news to note for Nov. 29, 2022 - BioWorld Online 11/29/2022, 17:41:50
CPHI China Pharma Holdings Inc. 3.14 29.6362 AstraZeneca Takes Personalized Approach To Cell Therapy With Neogene Buy - Scrip 11/29/2022, 12:37:43
CPHI China Pharma Holdings Inc. 3.14 29.6362 Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday’s Mid-Day Sessio - Benzinga 11/29/2022, 11:47:48
CNSP Cns Pharmaceuticals Inc 3.13 -18.2126 Sector Update: Health Care Stocks Unable to Complete Tuesday Recovery MarketScreener - Marketscreener.com 11/29/2022, 16:02:04
CNSP Cns Pharmaceuticals Inc 3.13 -18.2126 Healthcare Stocks Moving Tuesday: APEN, ONCS, VAXX, PALI, CNSP, CINC, NUTX, BEAT - InvestorsObserver 11/29/2022, 14:20:03
CNSP Cns Pharmaceuticals Inc 3.13 -18.2126 Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday’s Mid-Day Sessio - Benzinga 11/29/2022, 11:47:48
CNSP Cns Pharmaceuticals Inc 3.13 -18.2126 Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday - InvestorPlace 11/29/2022, 07:54:05
CNSP Cns Pharmaceuticals Inc 3.13 -18.2126 KemPharm Announces Appointment of Christopher Posner as New Independent Director - Yahoo Finance 11/29/2022, 07:30:00
SRNE Sorrento Therapeutics Inc 2.48 0.813 Sorrento Releases Positive Topline Results from the Phase I Study Completed in Australia and Preliminary Results from a Phase Ib Study in China with STI-1558, an Oral M(pro) Inhibitor as a Standalone Treatment for COVID-19 without the Need for Ritonavir - GlobeNewswire 11/29/2022, 14:06:27
SRNE Sorrento Therapeutics Inc 2.48 0.813 CAR T Cell Therapy Market See Incredible Growth 2022-2028 Novartis AG, McKinsey & Company, Bristol-Myers Squibb Company, Gilead Sciences, Inc., Amgen Inc. - Digital Journal 11/29/2022, 04:30:56
SRNE Sorrento Therapeutics Inc 2.48 0.813 Sorrento Therapeutics Inc (SRNE) Stock Has Fallen -12.96% This Week: Buy, Hold, or Sell? - InvestorsObserver 11/17/2022, 15:08:09
SRNE Sorrento Therapeutics Inc 2.48 0.813 Sorrento Therapeutics Inc (SRNE) Up 9.29% in Premarket Trading - InvestorsObserver 11/14/2022, 06:54:46
SRNE Sorrento Therapeutics Inc 2.48 0.813 Sorrento to Host Webcast to Discuss Newly Presented Clinical Data Demonstrating Significant Improvements in Therapeutic Outcomes in 10 of 10 Patients with Poorly Controlled Rheumatoid Arthritis - GlobeNewswire 11/13/2022, 15:02:34
CTLT Catalent Inc. 2.46 0.5115 Asia-Pacific Nasal Spray Market 2022: Size, Share, Demand, Trends, Growth, Industry Analysis till 20 - PharmiWeb.com 11/29/2022, 09:20:27
CTLT Catalent Inc. 2.46 0.5115 Biopharmaceuticals Manufacturing Consumables Testing Market 2022 Report with an exclusive discount on purchase Focusing on Current Trends and Leading Fortune Companies with Forecast to 2029: Alcami Corporation, Merck KGaA - Digital Journal 11/29/2022, 02:02:13
CTLT Catalent Inc. 2.46 0.5115 Global Life Sciences BPO Market Size Is Expected To Reach Around Usd $ 3,13,453.6 Million By 2030 - EIN News 11/29/2022, 00:59:00
CTLT Catalent Inc. 2.46 0.5115 U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.45% By Investing.com - Investing.com 11/28/2022, 16:25:00
CTLT Catalent Inc. 2.46 0.5115 CTLT stock spikes as Barclays says FDA cleared site violations (NYSE:CTLT) - Seeking Alpha 11/28/2022, 14:40:00
SINT SINTX Technologies Inc 2.37 17.8412 Sintx Technologies Inc. (NASDAQ: SINT) Analysts Suggest That Investors Hold Their Positions. - Stocks Register 11/29/2022, 08:02:25
SINT SINTX Technologies Inc 2.37 17.8412 Europe Spinal Implants Market By Product, Type, Application, Size, Growth and is Expected to Reach USD 4046.30 Million by 2028 - Digital Journal 11/28/2022, 08:37:15
SINT SINTX Technologies Inc 2.37 17.8412 Why Lufax Holding Shares Are Trading Lower By Over 11%; Here Are 21 Stocks Moving Premarket - Conformis ( - Benzinga 11/25/2022, 07:38:09
SINT SINTX Technologies Inc 2.37 17.8412 SINTX TECHNOLOGIES, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - Marketscreener.com 11/23/2022, 16:08:08
SINT SINTX Technologies Inc 2.37 17.8412 Wrist Replacement Orthopedic Devices Market is Expected to Hit at an estimated value of USD 405.78 million by - openPR 11/23/2022, 08:44:00
NAOV NanoVibronix Inc 2.34 -21.7886 Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday’s Mid-Day Sessio - Benzinga 11/29/2022, 11:47:48
NAOV NanoVibronix Inc 2.34 -21.7886 2022-11-29 NDAQ:NAOV Press Release NanoVibronix Inc. - Stockhouse 11/29/2022, 08:18:51
NAOV NanoVibronix Inc 2.34 -21.7886 NanoVibronix (NAOV) Announces $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - StreetInsider.com 11/29/2022, 08:13:59
NAOV NanoVibronix Inc 2.34 -21.7886 Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday - InvestorPlace 11/29/2022, 07:54:05
NAOV NanoVibronix Inc 2.34 -21.7886 Why Elbit Systems Shares Are Trading Lower By Over 10%; Here Are 24 Stocks Moving Premarket - Bilibili (N - Benzinga 11/29/2022, 07:28:25
JNJ Johnson & Johnson 2.14 -1.032 Horizon Therapeutics fields buyout interest from Amgen, J&J and Sanofi - Reuters 11/29/2022, 18:12:00
JNJ Johnson & Johnson 2.14 -1.032 Men’s Basketball to Host Johnson & Wales Wednesday Evening - Winston-Salem State 11/29/2022, 17:43:39
JNJ Johnson & Johnson 2.14 -1.032 OWL, WIO co-host a networking reception during Hawaiian Eye - Ophthalmology Times 11/29/2022, 17:05:50
JNJ Johnson & Johnson 2.14 -1.032 Eagles Release OT Roderick Johnson & RB Kennedy Brooks From PS - NFL Trade Rumors 11/29/2022, 16:33:03
JNJ Johnson & Johnson 2.14 -1.032 Johnson & Johnson stock outperforms competitors despite losses on the day - MarketWatch 11/29/2022, 16:33:00
AMGN AMGEN Inc. 1.9 -0.2229 Horizon Therapeutics fields buyout interest from Amgen, J&J and Sanofi - Reuters 11/29/2022, 18:12:00
AMGN AMGEN Inc. 1.9 -0.2229 3 rumors pushing around stocks today By Investing.com - Investing.com India 11/29/2022, 17:53:15
AMGN AMGEN Inc. 1.9 -0.2229 Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch 11/29/2022, 17:32:00
AMGN AMGEN Inc. 1.9 -0.2229 Noteworthy Tuesday Option Activity: AMGN, MDGL, NVCR - Nasdaq 11/29/2022, 16:51:00
AMGN AMGEN Inc. 1.9 -0.2229 Amgen Inc. stock falls Tuesday, underperforms market - MarketWatch 11/29/2022, 16:38:00
XFOR X4 Pharmaceuticals Inc 1.72 -9.6591 X4 PHARMACEUTICALS, INC : Regulation FD Disclosure, Other Events (form 8-K) - Marketscreener.com 11/29/2022, 16:08:08
XFOR X4 Pharmaceuticals Inc 1.72 -9.6591 Layoff Tracker 2022: Spectrum, Tricida, Pear Therapeutics and More Cull Staff BioSpace - BioSpace 11/29/2022, 11:02:44
XFOR X4 Pharmaceuticals Inc 1.72 -9.6591 Layoff Tracker: Curis, Adaptimmune plus 90+ more - FierceBiotech 11/28/2022, 15:37:30
XFOR X4 Pharmaceuticals Inc 1.72 -9.6591 Sanofi-backed Escient scores $120M series C for neuro-inflammatory pipeline - FierceBiotech 11/28/2022, 11:12:06
XFOR X4 Pharmaceuticals Inc 1.72 -9.6591 Eisai, Biogen rocked by 2nd lecanemab death report ahead of Alzheimer's data reveal - FierceBiotech 11/28/2022, 10:53:00
SCPH scPharmaceuticals Inc 1.71 4.4199 Insider Buying: scPharmaceuticals Inc. (NASDAQ:SCPH) Major Shareholder Purchases 762380 Shares of Stock - MarketBeat 11/29/2022, 18:21:17
SCPH scPharmaceuticals Inc 1.71 4.4199 Orin Hirschman Discloses Position in SCPH / scPharmaceuticals - Nasdaq 11/26/2022, 18:06:00
SCPH scPharmaceuticals Inc 1.71 4.4199 Does Scpharmaceuticals Inc (SCPH) Have What it Takes to be in Your Portfolio Tuesday? - InvestorsObserver 11/22/2022, 13:07:12
SCPH scPharmaceuticals Inc 1.71 4.4199 Financings for Nov. 22, 2022 BioWorld - BioWorld Online 11/22/2022, 11:00:00
SCPH scPharmaceuticals Inc 1.71 4.4199 Pre-Market Brief: Stocks Rebound As Bond Yields Fall, China's COVID Spike Remains In Focus - Barchart 11/22/2022, 05:20:00
MRTX Mirati Therapeutics Inc 1.7 -5.958 Regulus Therapeutics Announces Appointments of Industry Veterans, Drs. Rekha Garg and Claire Padgett, to Lead Clinical Development, Regulatory and Clinical Operations - Yahoo Finance 11/29/2022, 08:00:00
MRTX Mirati Therapeutics Inc 1.7 -5.958 Charles M. Baum Sells 69256 Shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX) Stock - MarketBeat 11/28/2022, 21:20:01
MRTX Mirati Therapeutics Inc 1.7 -5.958 Mirati Therapeutics to Present Late-Breaking Combination Results and Host Virtual Investor Relations Event at ESMO IO - Marketscreener.com 11/28/2022, 08:01:11
MRTX Mirati Therapeutics Inc 1.7 -5.958 6 biggest deal reports this week: Manchester United open to selling the club By Investing.com - Investing.com 11/26/2022, 17:02:00
MRTX Mirati Therapeutics Inc 1.7 -5.958 Seasonal Influenza Market to Proliferate at a CAGR of 6.1% During the Forecast Period (2022-2032), Assesses DelveInsight - Yahoo Finance 11/23/2022, 10:30:00
EAR Eargo Inc 1.57 -0.0182 Eargo, Inc. Welcomes Patient Square Capital As New Majority Owner Following Rights Offering - GlobeNewswire 11/29/2022, 16:06:00
EAR Eargo Inc 1.57 -0.0182 Pool Corporation to Present at the Nasdaq 47th Investor Conference - Yahoo Finance 11/29/2022, 16:05:00
EAR Eargo Inc 1.57 -0.0182 Completely-In-Canal (CIC) Hearing Aids Market by Product Type (No Control, Remote Control or Mobile Phone Control), Application (Hospital, Ear Clinic, Others), and Geography – Global Trends & Forecasts to 2019-2029 – Skegness Siren - Skegness Siren 11/26/2022, 04:07:59
EAR Eargo Inc 1.57 -0.0182 The Global Hearing Amplifiers Market is expected to grow by $2.62 bn during 2022-2026, accelerating at a CAGR of 5.8% during the forecast period - Yahoo Finance 11/18/2022, 03:00:00
EAR Eargo Inc 1.57 -0.0182 EARGO, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - Marketscreener.com 11/16/2022, 16:16:13
FGEN FibroGen Inc 1.57 1.4235 Thryv Therapeutics Inc. announces the appointment of Pharmaceutical Commercialization Expert Melissa Koomey, M.B.A., to its Board of Directors - Yahoo Finance 11/29/2022, 08:00:00
FGEN FibroGen Inc 1.57 1.4235 Global Aesthetic Injectables Market Key Players, Growth Opportunities, Future Challenges, Application, CAGR, Forecast by 2029 - Digital Journal 11/29/2022, 07:51:29
FGEN FibroGen Inc 1.57 1.4235 Myelodysplastic Syndrome (MDS) Treatment Market See Incredible Growth 2022-2028 Celgene Corporation, Otsuka Pharmaceutical Co., Ltd. Teva Pharmaceutical Industries Ltd. - Digital Journal 11/29/2022, 04:30:56
FGEN FibroGen Inc 1.57 1.4235 Where Does FibroGen Inc (FGEN) Stock Fall in the Biotechnology Field After It Has Fallen -4.54% This Week? - InvestorsObserver 11/28/2022, 14:25:35
FGEN FibroGen Inc 1.57 1.4235 Duchenne Muscular Dystrophy Market to Reach $2.1 Billion, Globally, by 2031 at 4.7% CAGR: Allied Market Research - PR Newswire UK 11/28/2022, 07:18:00
ENTA Enanta Pharmaceuticals Inc 1.57 2.018 Downgrade: Here's How Analysts See Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Performing In The Near Term - Simply Wall St 11/25/2022, 05:22:56
ENTA Enanta Pharmaceuticals Inc 1.57 2.018 Enanta Pharmaceuticals Full Year 2022 Earnings: Revenues Disappoint - Simply Wall St 11/23/2022, 05:23:49
ENTA Enanta Pharmaceuticals Inc 1.57 2.018 Enanta Pharmaceuticals, Inc. (ENTA) Q4 2022 Earnings Call Transcript - Seeking Alpha 11/21/2022, 18:10:00
ENTA Enanta Pharmaceuticals Inc 1.57 2.018 Enanta Pharmaceuticals (ENTA) Reports Q4 Loss, Lags Revenue Estimates - Zacks Investment Research 11/21/2022, 16:31:34
ENTA Enanta Pharmaceuticals Inc 1.57 2.018 Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2022 With Webcast and Conference Call Today at 4:30 p.m. ET - Business Wire 11/21/2022, 16:02:00
VTGN VistaGen Therapeutics Inc 0.81 29.7959 Bright Minds Biosciences Appoints Drug Development Executive Mark A. Smith M.D., Ph.D. as Chief Medical Officer - Financial Post 11/23/2022, 11:42:30
VTGN VistaGen Therapeutics Inc 0.81 29.7959 VISTAGEN THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Marketscreener.com 11/23/2022, 06:04:08
VTGN VistaGen Therapeutics Inc 0.81 29.7959 VISTAGEN THERAPEUTICS, INC. : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.com 11/22/2022, 06:04:12
VTGN VistaGen Therapeutics Inc 0.81 29.7959 Vistagen Therapeutics Inc (VTGN) Stock Has Risen 15.38% This Week: Buy, Hold, or Sell? - InvestorsObserver 11/17/2022, 12:53:10
VTGN VistaGen Therapeutics Inc 0.81 29.7959 VistaGen Therapeutics, Inc. (VTGN) Q2 2023 Earnings Call Transcript - Seeking Alpha 11/10/2022, 03:00:00
SNY Sanofi - ADR 0.8 1.6469 How Will the Market React to BioNTech SE - ADR (BNTX) Stock Getting a Bullish Rating - InvestorsObserver 11/29/2022, 11:06:38
SNY Sanofi - ADR 0.8 1.6469 Global Hepatitis B Vaccines Market 2022 Size and Share that Value Expected to Reach USD 1205.36 Mn Growing at CAGR of 2.28% Forecast to 2027 - Digital Journal 11/29/2022, 05:25:06
SNY Sanofi - ADR 0.8 1.6469 European ADRs Move Slightly Lower in Friday Trading - InvestorsObserver 11/11/2022, 11:14:45
SNY Sanofi - ADR 0.8 1.6469 Pharma Stock Roundup: Q3 Earnings of BAYRY, AZN, EU Nod for AZN, SNY RSV Vaccine - Yahoo Finance 11/11/2022, 03:00:00
SNY Sanofi - ADR 0.8 1.6469 Biogen Announces New CEO - NBC10 Boston 11/10/2022, 14:20:54
THMO ThermoGenesis Holdings Inc 0.79 20.0338 Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday’s Mid-Day Sessio - Benzinga 11/29/2022, 11:47:48
THMO ThermoGenesis Holdings Inc 0.79 20.0338 It’s still a bull thesis, just subverted: ThermoGenesis Holdings Inc. (THMO) - MZP News 11/29/2022, 08:24:00
THMO ThermoGenesis Holdings Inc 0.79 20.0338 Why Elbit Systems Shares Are Trading Lower By Over 10%; Here Are 24 Stocks Moving Premarket - Bilibili (N - Benzinga 11/29/2022, 07:28:25
THMO ThermoGenesis Holdings Inc 0.79 20.0338 Stem Cell Therapy Market Size to Record 8% CAGR Through 2028 Celgene Corp, BioTime Inc., Seneca Biopharma In - openPR 11/28/2022, 09:03:00
THMO ThermoGenesis Holdings Inc 0.79 20.0338 Blood Processing Devices and Consumables Market Prospering Due to Growing Health and Wellness Trend With CAGR - EIN News 11/16/2022, 03:00:00
VBLT Vascular Biogenics Ltd 0.79 3.268 13 Best Biotech Penny Stocks To Buy Now - Yahoo Finance 11/29/2022, 17:43:35
VBLT Vascular Biogenics Ltd 0.79 3.268 What is the Market's View on Vascular Biogenics Ltd (VBLT) Stock's Price and Volume Trends Tuesday? - InvestorsObserver 11/29/2022, 11:52:29
VBLT Vascular Biogenics Ltd 0.79 3.268 Can Vascular Biogenics Ltd. (VBLT) Remain Competitive? - The News Heater 11/29/2022, 11:50:03
VBLT Vascular Biogenics Ltd 0.79 3.268 Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday - Autodesk (NASDAQ - Benzinga 11/25/2022, 04:52:36
VBLT Vascular Biogenics Ltd 0.79 3.268 Why PagSeguro Digital Shares Are Trading Lower By 18%? Here Are 40 Stocks Moving In Wednesday’s Mid-Day S - Benzinga 11/23/2022, 13:27:38
JAGX Jaguar Health Inc 0.79 -3.2184 Jaguar Health Inc (JAGX) Stock: What Does the Chart Say Tuesday? - InvestorsObserver 11/29/2022, 11:50:13
JAGX Jaguar Health Inc 0.79 -3.2184 2nd Region lawmaker picked to lead Indiana Senate committee - The Times of Northwest Indiana 11/29/2022, 08:30:00
JAGX Jaguar Health Inc 0.79 -3.2184 19 Beauty Brands Participating in Giving Tuesday 2022: Where to Shop for Beauty Products That Give Back - Allure 11/29/2022, 08:06:00
JAGX Jaguar Health Inc 0.79 -3.2184 UK’s BooHoo Group Doubles Stake in Revolution Beauty - PYMNTS.com 11/28/2022, 17:07:30
JAGX Jaguar Health Inc 0.79 -3.2184 Why Jaguar Land Rover has swapped reach for the right audience - PR Week 11/24/2022, 09:30:21
GERN Geron Corp. 0.73 4.3668 Myelodysplastic Syndrome (MDS) Treatment Market See Incredible Growth 2022-2028 Celgene Corporation, Otsuka Pharmaceutical Co., Ltd. Teva Pharmaceutical Industries Ltd. - Digital Journal 11/29/2022, 04:30:56
GERN Geron Corp. 0.73 4.3668 Hygienic Night Pants Market Size 2022, Top Countries Segmented by Applications and Geography Trends – Skegness Siren - Skegness Siren 11/28/2022, 00:31:29
GERN Geron Corp. 0.73 4.3668 [2022-2030 Human Embryonic Stem Cells (Hesc) Market will Witness Substantial Growth With in-detailed Competit - openPR] 11/23/2022, 08:02:00
GERN Geron Corp. 0.73 4.3668 No JuJu Smith-Schuster or Mecole Hardman for Chiefs? Worked out OK as others stepped up - Kansas City Star 11/23/2022, 08:00:00
GERN Geron Corp. 0.73 4.3668 Should You Add Geron Corporation (GERN) Stock to Your Portfolio Friday? - InvestorsObserver 11/18/2022, 12:52:03
FREQ Frequency Therapeutics Inc 0.71 4.7619 Computer Vision and AI Solutions Pioneer Spacee Adds Thiel Capital Managing Director, Former PayPal SVP to Advisory Board - dallasinnovates.com 11/29/2022, 18:31:40
FREQ Frequency Therapeutics Inc 0.71 4.7619 Funding Roundup: Akeyless, Boost Security, CG Oncology, FogPharma, Kyte, Ordergroove, PayZen, Swell Energy, Vizit, WEKA, WorkJam, And Others - Pulse 2.0 11/29/2022, 12:57:00
FREQ Frequency Therapeutics Inc 0.71 4.7619 Nestlé reconsiders peanut allergy program two years after $2.6B buyout - Endpoints News 11/29/2022, 12:48:00
FREQ Frequency Therapeutics Inc 0.71 4.7619 SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Frequency Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors - Longview News-Journal 11/29/2022, 11:05:00
FREQ Frequency Therapeutics Inc 0.71 4.7619 Stoke Therapeutics to Present Data from the Company’s Dravet Syndrome Program at the American Epilepsy Society 2022 Annual Meeting - Yahoo Finance 11/29/2022, 07:30:00
PBYI Puma Biotechnology Inc 0.71 2.9478 Is Puma Biotechnology Inc (PBYI) Stock Over or Undervalued? - InvestorsObserver 11/28/2022, 11:56:19
PBYI Puma Biotechnology Inc 0.71 2.9478 Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday By Benzinga - Investing.com UK 11/28/2022, 06:10:00
PBYI Puma Biotechnology Inc 0.71 2.9478 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market by Product Type (Monotherapy, Combination Therapy), Application (Breast Cancer, Gastric Cancer, Ovarian Cancer, Others), and Geography – Global Trends & Forecasts to 2019-202 - Skegness Siren 11/26/2022, 01:35:29
PBYI Puma Biotechnology Inc 0.71 2.9478 Healthcare Stocks on the Move Friday: EUDA, PKBO, CGTX, NUTX, CHEK, NMTC, XGN, PBYI - InvestorsObserver 11/25/2022, 14:20:25
PBYI Puma Biotechnology Inc 0.71 2.9478 Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell? - InvestorsObserver 11/23/2022, 15:38:46
BSX Boston Scientific Corp. 0.67 2.0781 Urology Devices Market Size Will Attain USD 60.2 Billion by 2030 growing at 6.1% CAGR - Exclusive Report by Acumen Research and Consulting - GlobeNewswire 11/29/2022, 18:01:14
BSX Boston Scientific Corp. 0.67 2.0781 Boston Scientific Corp. stock outperforms market on strong trading day - MarketWatch 11/29/2022, 16:44:00
BSX Boston Scientific Corp. 0.67 2.0781 The Global Endoscopic Closure Devices Market is expected to grow by $633.13 mn from 2023-2027, accelerating at a CAGR of 7.16% during the forecast period - Yahoo Finance 11/29/2022, 13:23:00
BSX Boston Scientific Corp. 0.67 2.0781 The Global Duodenoscopes Market is Predicted to Surge at a CAGR of 5.2% by 2027, Assesses DelveInsight - GlobeNewswire 11/29/2022, 13:00:00
BSX Boston Scientific Corp. 0.67 2.0781 The Global Intracranial Aneurysms Market is Forecasted to Grow at a Significant CAGR of 9.10% by 2027, Assesses DelveInsight - GlobeNewswire 11/29/2022, 13:00:00
KMPH KemPharm Inc 0.65 -2.1413 KemPharm Announces Appointment of Christopher Posner as New Independent Director - Yahoo Finance 11/29/2022, 07:30:00
KMPH KemPharm Inc 0.65 -2.1413 Imago stock soars on $1.35B Merck buyout - BioWorld Online 11/21/2022, 12:00:00
KMPH KemPharm Inc 0.65 -2.1413 KemPharm, Inc. Forecasted to Post FY2023 Earnings of ($0.37) Per Share (NASDAQ:KMPH) - MarketBeat 11/21/2022, 02:36:47
KMPH KemPharm Inc 0.65 -2.1413 Analysts Have Just Cut Their KemPharm, Inc. (NASDAQ:KMPH) Revenue Estimates By 11% - Yahoo Eurosport UK 11/20/2022, 03:00:00
KMPH KemPharm Inc 0.65 -2.1413 KemPharm (NASDAQ:KMPH) Upgraded by StockNews.com to "Hold" - MarketBeat 11/19/2022, 03:00:00
NVO Novo Nordisk - ADR 0.52 0.099 Novo Nordisk Earns 92 RS Rating, Showing Market Leadership - Investor's Business Daily 11/29/2022, 11:25:00
NVO Novo Nordisk - ADR 0.52 0.099 Stocks Showing Market Leadership: Novo Nordisk ADR Earns 92 RS Rating - Investor's Business Daily 11/29/2022, 03:00:00
NVO Novo Nordisk - ADR 0.52 0.099 PFE: 1 High-Dividend Stock to Add to Your Portfolio if You Haven't Already - StockNews.com 11/28/2022, 13:40:30
NVO Novo Nordisk - ADR 0.52 0.099 Eurozone PMI Data Supports European Equities - Marketscreener.com 11/23/2022, 11:20:02
NVO Novo Nordisk - ADR 0.52 0.099 European ADRs Continue to Trend Higher in Monday Trading - InvestorsObserver 11/14/2022, 11:08:41
QURE uniQure N.V. 0.51 -4.0996 Other news to note for Nov. 29, 2022 - BioWorld Online 11/29/2022, 17:41:50
QURE uniQure N.V. 0.51 -4.0996 UniQure NV Says Preclinical Data Support AMT-260 Gene Therapy's Safety, Tolerability - Marketscreener.com 11/29/2022, 15:33:03
QURE uniQure N.V. 0.51 -4.0996 BMS Terminates 2015 Gene Therapy Pact with uniQure - BioSpace 11/29/2022, 15:21:32
QURE uniQure N.V. 0.51 -4.0996 Where Will Uniqure NV (QURE) Stock Go Next After It Has Risen 21.37% in a Week? - InvestorsObserver 11/29/2022, 14:51:45
QURE uniQure N.V. 0.51 -4.0996 uniQure Highlights Therapeutic Potential of AMT-260 in Refractory Temporal Lobe Epilepsy (rTLE) at Virtual Research & Development Event - Yahoo Finance 11/29/2022, 11:00:00
IMVT Immunovant Inc 0.51 -7.9851 Immunovant, Inc. (NASDAQ:IMVT) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat 11/29/2022, 03:15:33
IMVT Immunovant Inc 0.51 -7.9851 Are Medical Stocks Lagging BioVie (BIVI) This Year? - Nasdaq 11/25/2022, 09:40:00
IMVT Immunovant Inc 0.51 -7.9851 Immunovant (IMVT) Rises More Than 150% in 3 Months: Here's How - Zacks Investment Research 11/17/2022, 03:00:00
IMVT Immunovant Inc 0.51 -7.9851 Is it Time to Dump Immunovant Inc (IMVT) Stock After it Has Gained 4.43% in a Week? - InvestorsObserver 11/08/2022, 12:40:23
IMVT Immunovant Inc 0.51 -7.9851 Wells Fargo Adjusts Price Target on Immunovant to $10 From $7, Maintains Equal-Weight Rating - Marketscreener.com 11/08/2022, 12:01:02
BMRN Biomarin Pharmaceutical Inc. - Registered Shares 0.39 0 Lysosomal Storage Diseases Market 2022 Growth Factors, Opportunities, Ongoing Trends and Key Players 2032 - Digital Journal 11/28/2022, 21:27:58
BMRN Biomarin Pharmaceutical Inc. - Registered Shares 0.39 0 Yet another Lupin plant in India is in hot water with the FDA - FiercePharma 11/28/2022, 11:22:56
BMRN Biomarin Pharmaceutical Inc. - Registered Shares 0.39 0 BioMarin Announces Advancements in FDA Review of ROCTAVIAN™ (Valoctocogene Roxaparvovec) for Adults with Severe Hemophilia A - Investor Relations : BioMarin 11/23/2022, 08:34:16
BMRN Biomarin Pharmaceutical Inc. - Registered Shares 0.39 0 GSK, J&J, and AZ top 2022 drug access index - FiercePharma 11/16/2022, 03:00:00
BMRN Biomarin Pharmaceutical Inc. - Registered Shares 0.39 0 PTC Therapeutics: PKU Trial News Likely To Shore Up Share Price - Seeking Alpha 11/15/2022, 03:00:00
ATHA Athira Pharma Inc 0.38 1.0563 Athira Pharma Highlights Therapeutic Potential of Fosgonimeton in Presentation of Additional Biomarker Data in Mild-to-Moderate Alzheimer's Disease Patients from ACT-AD Phase 2 Study at CTAD Conference - GlobeNewswire 11/29/2022, 11:00:00
ATHA Athira Pharma Inc 0.38 1.0563 Athira Pharma to Present Preclinical Data Highlighting Therapeutic Potential of ATH-1105 in ALS at the 33rd International Symposium - Marketscreener.com 11/29/2022, 10:09:20
ATHA Athira Pharma Inc 0.38 1.0563 Athira Pharma to Present Preclinical Data Highlighting Therapeutic Potential of ATH-1105 in ALS at the 33rd International Symposium on ALS/MND - Marketscreener.com 11/28/2022, 07:01:02
ATHA Athira Pharma Inc 0.38 1.0563 Athira Pharma, Inc. (NASDAQ:ATHA) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat 11/20/2022, 01:10:55
ATHA Athira Pharma Inc 0.38 1.0563 ATHIRA PHARMA, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K) - Marketscreener.com 11/18/2022, 16:09:10
ABCM Abcam - ADR (Sponsored) 0.38 -9.1286 Heightened apoptotic priming of vascular cells across tissues and life span predisposes them to cancer therapy–induced toxicities - Science 11/09/2022, 03:00:00
ABCM Abcam - ADR (Sponsored) 0.38 -9.1286 The 7 Best Stocks Under $15 to Buy Now - InvestorPlace 11/08/2022, 03:00:00
ABCM Abcam - ADR (Sponsored) 0.38 -9.1286 AIM Delisting – Abcam plc - Abcam plc 10/17/2022, 02:28:49
ABCM Abcam - ADR (Sponsored) 0.38 -9.1286 Interim results for the period ended 30 June 2022 – Abcam plc - Abcam plc 06/30/2022, 03:00:00
ABCM Abcam - ADR (Sponsored) 0.38 -9.1286 Appointment of Vice President of Investor Relations – Abcam plc - Abcam plc 06/27/2022, 03:00:00
NVCR NovoCure Ltd 0.37 6.1376 Noteworthy Tuesday Option Activity: AMGN, MDGL, NVCR - Nasdaq 11/29/2022, 16:51:00
NVCR NovoCure Ltd 0.37 6.1376 Teck Resources taps insider Crystal Prystai for CFO - Yahoo Finance 11/29/2022, 13:50:05
NVCR NovoCure Ltd 0.37 6.1376 Is Novocure Ltd (NVCR) a Stock to Watch After Losing -0.27% This Week? - InvestorsObserver 11/29/2022, 12:00:41
NVCR NovoCure Ltd 0.37 6.1376 After Record Cyber Monday Sales, Analysts Upgrade or Downgrade Affirm, Roku, UPS and More - 24/7 Wall St. 11/29/2022, 11:52:25
NVCR NovoCure Ltd 0.37 6.1376 FedEx To Rally Over 25%? Here Are 10 Other Price Target Changes For Tuesday By Benzinga - Investing.com UK 11/29/2022, 08:40:00
PETQ PetIQ Inc 0.3 -1.7668 Simple Mills Appoints Sheryl O'Loughlin to Board of Directors - PetIQ (NASDAQ:PETQ) - Benzinga 11/29/2022, 08:03:00
PETQ PetIQ Inc 0.3 -1.7668 Pet Dental Care Market Study Providing Information on Top Key Players Mars, CVS Group, MedVet, Petco And More - Digital Journal 11/29/2022, 07:41:32
PETQ PetIQ Inc 0.3 -1.7668 Two dead, one wounded in shooting at Baxter Springs residence - Yahoo News 11/29/2022, 00:12:32
PETQ PetIQ Inc 0.3 -1.7668 Club Q shooting suspect's mom faces charges, documents show - Yahoo News 11/29/2022, 00:02:30
PETQ PetIQ Inc 0.3 -1.7668 Police complete scene investigation of Club Q shooting, update number of victims - Yahoo! Voices 11/29/2022, 00:01:56
LNTH Lantheus Holdings Inc 0.27 -0.3942 Deal Watch: BMS Backs Out Of UniQure Gene Therapy Collaboration - Scrip 11/29/2022, 18:32:45
LNTH Lantheus Holdings Inc 0.27 -0.3942 Should You Add Hagerty (HGTY) to Your Portfolio? - Yahoo Finance 11/29/2022, 12:29:39
LNTH Lantheus Holdings Inc 0.27 -0.3942 Here’s Why Greenhaven Road Capital Sold Teladoc Health (TDOC) - Yahoo Finance 11/29/2022, 12:29:20
LNTH Lantheus Holdings Inc 0.27 -0.3942 ERI’s John Shegerian Points to FTX Failure as Prime Example Why Qualified, Ethical Governance is Essential in Business - Yahoo Finance 11/29/2022, 11:27:00
LNTH Lantheus Holdings Inc 0.27 -0.3942 Lantheus Announces Appointment of Amanda Morgan as Senior Vice President, Commercial - Yahoo Finance 11/29/2022, 08:00:00
SGEN Seagen Inc 0.27 -3.1513 Horizon Therapeutics in Separate Sale Talks With Amgen, Sanofi, J&J - Bloomberg 11/29/2022, 18:57:50
SGEN Seagen Inc 0.27 -3.1513 Steven Cohen Loads Up on Workday, Dumps Coca-Cola - GuruFocus.com 11/29/2022, 18:27:45
SGEN Seagen Inc 0.27 -3.1513 Roche Withdraws Tecentriq's Frontline Bladder Cancer Indication, Ceding Market To Keytruda - Scrip 11/29/2022, 17:25:16
SGEN Seagen Inc 0.27 -3.1513 Incyte Corp. stock falls Tuesday, still outperforms market - MarketWatch 11/29/2022, 17:09:00
SGEN Seagen Inc 0.27 -3.1513 The Global Duodenoscopes Market is Predicted to Surge at a CAGR of 5.2% by 2027, Assesses DelveInsight - GlobeNewswire 11/29/2022, 13:00:00
SIGA SIGA Technologies Inc 0.27 0.1112 World Health Organization renames monkeypox as mpox (NASDAQ:SIGA) - Seeking Alpha 11/28/2022, 06:51:00
SIGA SIGA Technologies Inc 0.27 0.1112 So far only 2 cases of monkeypox detected Print Edition - The Sunday Times, Sri Lanka - The Sunday Times Sri Lanka 11/26/2022, 19:48:52
SIGA SIGA Technologies Inc 0.27 0.1112 Monkeypox Treatment Market Future Business Opportunities 2022-2028 SIGA Technologies Inc., Chimerix, Inc., Bavarian Nordic, Sanofi SA. - Digital Journal 11/21/2022, 08:00:33
SIGA SIGA Technologies Inc 0.27 0.1112 Global Biodefense Market Report to 2030 - Featuring Altimmune, Emergent BioSolutions, SIGA Technologies and Ichor Medical Systems Among Others - ResearchAndMarkets.com - Business Wire 11/21/2022, 05:53:00
SIGA SIGA Technologies Inc 0.27 0.1112 SIGA Technologies is experiencing unusually high option volume. - Best Stocks 11/17/2022, 19:32:52
PSTV Plus Therapeutics Inc 0.26 -3.2625 Deal Watch: BMS Backs Out Of UniQure Gene Therapy Collaboration - Scrip 11/29/2022, 18:32:45
PSTV Plus Therapeutics Inc 0.26 -3.2625 Other news to note for Nov. 29, 2022 - BioWorld Online 11/29/2022, 17:41:50
PSTV Plus Therapeutics Inc 0.26 -3.2625 ALLOGENE THERAPEUTICS, INC. : Other Events (form 8-K) - Marketscreener.com 11/29/2022, 15:35:03
PSTV Plus Therapeutics Inc 0.26 -3.2625 Here's How to Find Cheap Stocks Under $10 to Buy for December - Yahoo Finance 11/29/2022, 12:57:05
PSTV Plus Therapeutics Inc 0.26 -3.2625 AstraZeneca Takes Personalized Approach To Cell Therapy With Neogene Buy - Scrip 11/29/2022, 12:37:43
AZN Astrazeneca plc - ADR 0.26 -0.1057 AstraZeneca PLC ADR outperforms market despite losses on the day - MarketWatch 11/29/2022, 16:40:00
AZN Astrazeneca plc - ADR 0.26 -0.1057 Moderna Inc. stock falls Wednesday, underperforms market - MarketWatch 11/23/2022, 16:31:00
AZN Astrazeneca plc - ADR 0.26 -0.1057 Pharma Co. Gains Approval for SARS-CoV-2 Drug Trending Company - Streetwise Reports 11/23/2022, 08:29:36
AZN Astrazeneca plc - ADR 0.26 -0.1057 Inovio Pharmaceuticals Inc. stock falls Tuesday, underperforms market - MarketWatch 11/22/2022, 17:01:00
AZN Astrazeneca plc - ADR 0.26 -0.1057 AbbVie Inc. stock rises Tuesday, outperforms market - MarketWatch 11/22/2022, 16:32:00
ZTS Zoetis Inc 0.25 -0.189 Equal Weight Maintains Significant Lead Over S&P 500 - ETF Trends 11/29/2022, 14:59:02
ZTS Zoetis Inc 0.25 -0.189 Hoof Protection and Health Care Seminar - Morning Ag Clips - 11/29/2022, 13:03:35
ZTS Zoetis Inc 0.25 -0.189 Top Stock Reports for Procter & Gamble, Coca-Cola & Progressive - Nasdaq 11/29/2022, 10:42:00
ZTS Zoetis Inc 0.25 -0.189 2022-11-29 NYSE:ZTS Press Release Zoetis Inc. Class A - Stockhouse 11/29/2022, 09:18:44
ZTS Zoetis Inc 0.25 -0.189 Poultry Disinfectant Global Market Report 2022: Ukraine-Russia War Impact - Yahoo Finance 11/29/2022, 08:48:00
STAA Staar Surgical Co. 0.25 -5.532 Staar Surgical Opens Training Center in Lake Forest - Orange County Business Journal 11/29/2022, 15:59:23
STAA Staar Surgical Co. 0.25 -5.532 Surgical Ophthalmology Market Latest Technological Developments Report by 2030 - openPR 11/29/2022, 01:45:00
STAA Staar Surgical Co. 0.25 -5.532 Microkeratome Market Development and Future Demand Analysis Report 2020-2030 - Digital Journal 11/28/2022, 20:22:38
STAA Staar Surgical Co. 0.25 -5.532 Returns On Capital Are Showing Encouraging Signs At STAAR Surgical (NASDAQ:STAA) - Yahoo Finance 11/28/2022, 13:18:05
STAA Staar Surgical Co. 0.25 -5.532 Corneal Topographers Market 2022 Generated Opportunities for Business Development Forecasts Up to 2028: Alcon plc., Abbott Laboratories, Topcon Corporation, Allergan - Digital Journal 11/28/2022, 09:25:01
OM Outset Medical Inc 0.25 5.9192 Tesla, Paypal add more lobbyists - POLITICO - POLITICO 11/29/2022, 18:10:00
OM Outset Medical Inc 0.25 5.9192 Federal Judge Refuses to Dismiss COVID-19 Fraudulent Billing Scheme Claim Brought by Aetna New Jersey Law Journal - Law.com 11/29/2022, 17:28:26
OM Outset Medical Inc 0.25 5.9192 How FYidoctors mastered the art of the merger - The Globe and Mail 11/29/2022, 17:05:14
OM Outset Medical Inc 0.25 5.9192 Part 1, FINAL UPDATE – Local Election Postmortem: Board of Supes Goes MAGA, Redding Gets Redder – anewscafe.com - A News Cafe 11/29/2022, 16:41:44
OM Outset Medical Inc 0.25 5.9192 Bias Suit Ruling Offers Disability Accommodation Guidelines - Law360 11/29/2022, 15:20:00
ACRS Aclaris Therapeutics Inc 0.25 0 Astrazeneca paying up to $320M to acquire individualized TCR T-cell therapy developer Neogene - BioWorld Online 11/29/2022, 12:00:00
ACRS Aclaris Therapeutics Inc 0.25 0 Aclaris Therapeutics and Pediatrix Therapeutics Announce License Agreement for ATI-1777 in Greater China - GlobeNewswire 11/29/2022, 07:00:00
ACRS Aclaris Therapeutics Inc 0.25 0 Androgenetic Alopecia Treatment Market Value Projected to Expand by 2030 Histogen Inc, Cipla Limited, Aclaris Therapeutics - Digital Journal 11/28/2022, 09:56:20
ACRS Aclaris Therapeutics Inc 0.25 0 Alopecia Treatment Market Research Report 2022 – Size, Share, Emerging Trends, Historic Analysis, Industry Growth Factors, Forecast to 2028 Aclaris Therapeutics, Inc., Fagron, Follicum AB, Cipla - Digital Journal 11/23/2022, 06:35:38
ACRS Aclaris Therapeutics Inc 0.25 0 Aclaris Therapeutics Announces Key Leadership Transitions - GlobeNewswire 11/22/2022, 16:01:00
ALLO Allogene Therapeutics Inc 0.25 -8.3821 Allogene Therapeutics R&D Showcase Features Hematologic and Solid Tumor Advances Across its AlloCAR T™ Platform - GlobeNewswire 11/29/2022, 15:30:12
ALLO Allogene Therapeutics Inc 0.25 -8.3821 Nestlé reconsiders peanut allergy program two years after $2.6B buyout - Endpoints News 11/29/2022, 12:48:00
ALLO Allogene Therapeutics Inc 0.25 -8.3821 Boehringer Ingelheim buys CD38 drug; Merck bets on machine learning in antibody design - Endpoints News 11/29/2022, 10:57:00
ALLO Allogene Therapeutics Inc 0.25 -8.3821 Viatris withdraws accelerated approval for topical antimicrobial 24 years later - Endpoints News 11/29/2022, 10:53:00
ALLO Allogene Therapeutics Inc 0.25 -8.3821 Lundbeck-partnered preclinical biotech nabs Series A from AstraZeneca - Endpoints News 11/29/2022, 08:00:00
NVAX Novavax, Inc. 0.25 0.9615 World Health Organization Updates Emergency Use Listing for Novavax Nuvaxovid COVID-19 Vaccine as a Primary Series in Adolescents and as a Booster in Adults - Novavax Investor Relations 11/29/2022, 09:03:17
NVAX Novavax, Inc. 0.25 0.9615 Shionogi applies for COVID-19 vaccine approval, 1st as Japan-made - Kyodo News Plus 11/24/2022, 02:40:10
NVAX Novavax, Inc. 0.25 0.9615 Seasonal Influenza Market to Proliferate at a CAGR of 6.1% During the Forecast Period (2022-2032), Assesses DelveInsight - Yahoo Finance 11/23/2022, 10:30:00
NVAX Novavax, Inc. 0.25 0.9615 COVID-19 Clinical Trials Market Size Predicted to Increase at a Positive CAGR INOVIO Pharmaceuticals, AbbVie Inc., BioNTech SE, Novavax, Takeda - Digital Journal 11/23/2022, 08:10:04
NVAX Novavax, Inc. 0.25 0.9615 Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday - Agora (NASDAQ:API), AGBA A - Benzinga 11/23/2022, 02:48:25
PSTX Poseida Therapeutics Inc 0.14 9.0686 Is Poseida Therapeutics Inc (PSTX) a Bad Choice in Biotechnology Tuesday? - InvestorsObserver 11/29/2022, 11:57:26
PSTX Poseida Therapeutics Inc 0.14 9.0686 Human Gene Therapy Market by Product Type (Non-viral Vectors, Viral Vectors), Application (Neurological Diseases, Cancer, DMD (Duchenne Muscular Dystrophy), Hepatological Diseases, Others), and Geography – Global Trends & Forecasts to 2019- - Skegness Siren 11/27/2022, 02:26:08
PSTX Poseida Therapeutics Inc 0.14 9.0686 AAV Vectors in Gene Therapy - Pipeline Insight, 2022 - ResearchAndMarkets.com - Business Wire 11/22/2022, 11:59:00
PSTX Poseida Therapeutics Inc 0.14 9.0686 Should You Add Poseida Therapeutics Inc (PSTX) Stock to Your Portfolio Monday? - InvestorsObserver 11/21/2022, 12:59:31
PSTX Poseida Therapeutics Inc 0.14 9.0686 Poseida Therapeutics: Early Stage CAR-T Developer Seeing Big Pharma Interest (NASDAQ:PSTX) - Seeking Alpha 11/18/2022, 03:32:00
CCCC C4 Therapeutics Inc 0.14 0.6289 Is C4 Therapeutics Inc (CCCC) a Stock to Watch After Losing -16.53% This Week? - InvestorsObserver 11/29/2022, 14:52:39
CCCC C4 Therapeutics Inc 0.14 0.6289 Why Canoo Shares Are Trading Higher By Over 12%? Here Are 32 Stocks Moving In Friday’s Mid-Day Session - - Benzinga 11/25/2022, 12:01:57
CCCC C4 Therapeutics Inc 0.14 0.6289 C4 Therapeutics Inc (CCCC) has fallen -17.08% in a Week, Should You Sell? - InvestorsObserver 11/25/2022, 11:42:58
CCCC C4 Therapeutics Inc 0.14 0.6289 US Stocks Mixed On Black Friday; Dow Rises Over 100 Points - Check-Cap (NASDAQ:CHEK), C4 Therapeutics (NA - Benzinga 11/25/2022, 10:06:54
CCCC C4 Therapeutics Inc 0.14 0.6289 Captor Therapeutics Reports Q3 2022 Results and Provides Business Update - GlobeNewswire 11/25/2022, 08:00:00
NRIX Nurix Therapeutics Inc 0.14 3.348 Til Therapy Market May Set New Growth Story Nurix Therapeutics, Achilles Therapeutics, Intima Bioscience - Digital Journal 11/28/2022, 07:32:06
NRIX Nurix Therapeutics Inc 0.14 3.348 We're Keeping An Eye On Nurix Therapeutics' (NASDAQ:NRIX) Cash Burn Rate - Simply Wall St 11/28/2022, 05:20:48
NRIX Nurix Therapeutics Inc 0.14 3.348 Nurix Announces DeTIL-0255 Scientific Presentations at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) and Successful Completion of DeTIL-0255 Phase 1 Safety Run-in - GlobeNewswire 11/10/2022, 03:00:00
NRIX Nurix Therapeutics Inc 0.14 3.348 Cathie Wood's ARKK ETF Heads for Best Day Ever as Risk Assets Surge - Bloomberg 11/10/2022, 03:00:00
NRIX Nurix Therapeutics Inc 0.14 3.348 Nurix Therapeutics Announces Presentations at the 64th American Society of Hematology (ASH) Annual Meeting - GlobeNewswire 11/03/2022, 03:00:00
NKTR Nektar Therapeutics 0.14 -5.8065 Mirum blames enrollment woes for halting phase 2 trial for pregnancy liver disorder - FierceBiotech 11/29/2022, 09:56:03
NKTR Nektar Therapeutics 0.14 -5.8065 AstraZeneca inks $200M solid tumor TCR cell therapy buyout - FierceBiotech 11/29/2022, 07:01:16
NKTR Nektar Therapeutics 0.14 -5.8065 Dual drug nanoparticle could curb chemo resistance - FierceBiotech 11/28/2022, 15:37:30
NKTR Nektar Therapeutics 0.14 -5.8065 Sarepta-partnered Hansa touts new phase 2 data of one-trick pony immunological treatment - FierceBiotech 11/28/2022, 15:35:00
NKTR Nektar Therapeutics 0.14 -5.8065 Master and PhD programs in pharmaceutical sciences underway Binghamton News - Binghamton 11/28/2022, 14:49:56
MDGL Madrigal Pharmaceuticals Inc 0.14 4.8362 Noteworthy Tuesday Option Activity: AMGN, MDGL, NVCR - Nasdaq 11/29/2022, 16:51:00
MDGL Madrigal Pharmaceuticals Inc 0.14 4.8362 The Liver Fibrosis Market Size in the 7MM was USD 2225 million in 2021 - Digital Journal 11/29/2022, 16:11:05
MDGL Madrigal Pharmaceuticals Inc 0.14 4.8362 Akero Therapeutics: What Is Making The Stock Tick (NASDAQ:AKRO) - Seeking Alpha 11/23/2022, 11:01:00
MDGL Madrigal Pharmaceuticals Inc 0.14 4.8362 Notable Friday Option Activity: MDGL, SAVA, MSTR - Nasdaq 11/18/2022, 03:00:00
MDGL Madrigal Pharmaceuticals Inc 0.14 4.8362 Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Short Interest Up 17.4% in October - MarketBeat 11/14/2022, 03:00:00
RLMD Relmada Therapeutics Inc 0.14 -6.1224 Janssen's Spravato Beats Antipsychotic In Depression Trial Designed To Increase Uptake - Scrip 11/24/2022, 11:56:36
RLMD Relmada Therapeutics Inc 0.14 -6.1224 PERCEPTIVE ADVISORS LLC Buys 4, Sells 1 in 3rd Quarter - GuruFocus.com 11/15/2022, 11:00:24
RLMD Relmada Therapeutics Inc 0.14 -6.1224 Can Relmada Therapeutics Inc (RLMD) Stock Rise to the Top of Healthcare Sector Monday? - InvestorsObserver 11/14/2022, 12:56:52
RLMD Relmada Therapeutics Inc 0.14 -6.1224 Neuroone Medical Technologies Corp (NMTC) Up 7.45% in Premarket Trading - InvestorsObserver 11/14/2022, 06:54:42
RLMD Relmada Therapeutics Inc 0.14 -6.1224 Relmada Therapeutics, Inc. (RLMD) Q3 2022 Earnings Call Transcript - Seeking Alpha 11/12/2022, 03:00:00
VBIV VBI Vaccines Inc. 0.14 -6.5421 VBI Vaccines Inc. (NASDAQ:VBIV) is a stock that investors should take a bite out of. - The Dwinnex 11/29/2022, 13:32:00
VBIV VBI Vaccines Inc. 0.14 -6.5421 Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2022 - Yahoo Finance 11/29/2022, 10:58:00
VBIV VBI Vaccines Inc. 0.14 -6.5421 Gene therapy Hemgenix gains FDA clearance for hemophilia B - BioWorld Online 11/23/2022, 13:16:02
VBIV VBI Vaccines Inc. 0.14 -6.5421 Novavax Inc. stock falls Tuesday, underperforms market - MarketWatch 11/22/2022, 17:13:00
VBIV VBI Vaccines Inc. 0.14 -6.5421 VBI Vaccines Presents Additional Phase 1/2a Data from VBI-1901 in Recurrent GBM at the 2022 Society for Neuro-Oncology (SNO) Annual Meeting - VBI Vaccines 11/22/2022, 08:28:33
PRAX Praxis Precision Medicines Inc 0.14 9.1837 Praxis Precision Medicines to Present at the American Epilepsy Society 2022 Annual Meeting - GlobeNewswire 11/28/2022, 16:05:00
PRAX Praxis Precision Medicines Inc 0.14 9.1837 Eisai, Biogen rocked by 2nd lecanemab death report ahead of Alzheimer's data reveal - FierceBiotech 11/28/2022, 10:53:00
PRAX Praxis Precision Medicines Inc 0.14 9.1837 AstraZeneca beefs up COPD pipeline with $400M biobuck bet on C4X program - FierceBiotech 11/28/2022, 06:44:52
PRAX Praxis Precision Medicines Inc 0.14 9.1837 What is the Market's View on Praxis Precision Medicines Inc (PRAX) Stock's Price and Volume Trends Tuesday? - InvestorsObserver 11/22/2022, 12:48:45
PRAX Praxis Precision Medicines Inc 0.14 9.1837 Is Praxis Precision Medicines Inc (PRAX) a Stock to Watch After Gaining 22.50% This Week? - InvestorsObserver 11/09/2022, 11:52:14
NVST Envista Holdings Corp 0.14 -0.9666 Global Dental Restoration Market Report 2022 to 2027: Rising Demand for Dental Implants is Driving Growth - Yahoo Finance 11/29/2022, 07:53:00
NVST Envista Holdings Corp 0.14 -0.9666 Form N-CSR EATON VANCE GROWTH TRUST For: Sep 30 - StreetInsider.com 11/28/2022, 14:31:25
NVST Envista Holdings Corp 0.14 -0.9666 Intraoral Scanners Market 2023-2027: 5-Year (2017-2021) Historic Industry Size & Analysis of 15 Vendors and 7 Countries - Technavio - PR Newswire 11/28/2022, 09:00:00
NVST Envista Holdings Corp 0.14 -0.9666 Dental Equipment Market Forecast Report with Statistics on Latest Industry Developments & Global Trends - Digital Journal 11/24/2022, 08:49:01
NVST Envista Holdings Corp 0.14 -0.9666 Dental Consumables Market Growth Strategy 2022 Geographical Segmentation, Investment Opportunities, Future Trends, Demand, PEST Analysis and Forecast to 2028 - Digital Journal 11/16/2022, 09:01:40
SYK Stryker Corp. 0.14 -0.0308 Urology Devices Market Size Will Attain USD 60.2 Billion by 2030 growing at 6.1% CAGR - Exclusive Report by Acumen Research and Consulting - GlobeNewswire 11/29/2022, 18:01:14
SYK Stryker Corp. 0.14 -0.0308 Zimmer Biomet Holdings Inc. stock outperforms market on strong trading day - MarketWatch 11/29/2022, 17:49:00
SYK Stryker Corp. 0.14 -0.0308 Stryker Corp. stock outperforms market despite losses on the day - MarketWatch 11/29/2022, 17:38:00
SYK Stryker Corp. 0.14 -0.0308 Henry Schein Inc. stock rises Tuesday, outperforms market - MarketWatch 11/29/2022, 17:07:00
SYK Stryker Corp. 0.14 -0.0308 Edwards Lifesciences Corp. stock falls Tuesday, underperforms market - MarketWatch 11/29/2022, 16:58:00
TSHA Taysha Gene Therapies Inc 0.14 -1.8265 Taysha Gene Therapies to Participate in JMP Securities Hematology and Oncology Summit - GlobeNewswire 11/29/2022, 16:01:00
TSHA Taysha Gene Therapies Inc 0.14 -1.8265 Gene therapy R&D market is projected to grow at a CAGR of 30.1% by 2032: Visiongain Reports Ltd - Yahoo Finance 11/29/2022, 12:29:00
TSHA Taysha Gene Therapies Inc 0.14 -1.8265 Sarepta-partnered Hansa touts new phase 2 data of one-trick pony immunological treatment - FierceBiotech 11/28/2022, 15:35:00
TSHA Taysha Gene Therapies Inc 0.14 -1.8265 Is Taysha Gene Therapies Inc (TSHA) a Stock to Watch After Losing -3.04% This Week? - InvestorsObserver 11/28/2022, 13:04:19
TSHA Taysha Gene Therapies Inc 0.14 -1.8265 Eisai, Biogen rocked by 2nd lecanemab death report ahead of Alzheimer's data reveal - FierceBiotech 11/28/2022, 10:53:00
GRAY Graybug Vision Inc 0.14 0.639 Glaucoma Pipeline Assessment 70+ Companies & 70+ Drugs DelveInsight - Digital Journal 11/29/2022, 16:16:47
GRAY Graybug Vision Inc 0.14 0.639 Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 10.74% by 2032: Visiongain Reports Ltd - Yahoo Finance 11/28/2022, 12:08:00
GRAY Graybug Vision Inc 0.14 0.639 Ocular Drug Delivery Sales Market is expected to reach a value of USD 1721231.5 Million By 2027- OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc, EyeGate Pharma, Valeant Pharmaceuticals International, Inc, Envisia Therapeutics, Clearside - Skegness Siren 11/26/2022, 07:15:49
GRAY Graybug Vision Inc 0.14 0.639 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BNFT, GRAY - Graybug Vision (NASDAQ:GRAY), Benef - Benzinga 11/24/2022, 07:30:51
GRAY Graybug Vision Inc 0.14 0.639 GRAYBUG VISION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graybug Vision, Inc. - GRAY - Business Wire 11/23/2022, 20:48:00
MACK Merrimack Pharmaceuticals Inc 0.14 -0.5872 Should You Accumulate Merrimack Pharmaceuticals Inc (MACK) Stock Monday Morning? - InvestorsObserver 11/21/2022, 08:20:44
MACK Merrimack Pharmaceuticals Inc 0.14 -0.5872 Neurobo Pharmaceuticals Inc (NRBO) is lower by 2.29% Monday In Premarket Trading - InvestorsObserver 11/21/2022, 08:06:49
MACK Merrimack Pharmaceuticals Inc 0.14 -0.5872 The Zacks Analyst Blog Highlights Merrimack Pharmaceuticals, Moderna and Seagen - Nasdaq 11/17/2022, 03:00:00
MACK Merrimack Pharmaceuticals Inc 0.14 -0.5872 Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer - PR Newswire 11/15/2022, 09:00:00
MACK Merrimack Pharmaceuticals Inc 0.14 -0.5872 Novel Drug Delivery Systems in Cancer Therapy Market to reach over USD 50.45 billion by the year 2030 - EIN News 11/14/2022, 06:58:00
PRFX PainReform Ltd 0.14 -10.4167 Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday - Autodesk (NASDAQ - Benzinga 11/25/2022, 04:52:36
PRFX PainReform Ltd 0.14 -10.4167 Why PagSeguro Digital Shares Are Trading Lower By 18%? Here Are 40 Stocks Moving In Wednesday’s Mid-Day S - Benzinga 11/23/2022, 13:27:38
PRFX PainReform Ltd 0.14 -10.4167 PainReform Provides Business Update for the Third Quarter of 2022 - Yahoo Finance 11/15/2022, 03:00:00
PRFX PainReform Ltd 0.14 -10.4167 PainReform Provides Further Update on Manufacturing of PRF-110 - GlobeNewswire 11/08/2022, 08:30:00
PRFX PainReform Ltd 0.14 -10.4167 PainReform Provides PRF-110 Manufacturing Update - GlobeNewswire 10/04/2022, 03:00:00
LCI Lannett Co., Inc. 0.13 -8.0496 Aclaris Therapeutics Announces Key Leadership Transitions - MyChesCo 11/28/2022, 02:00:24
LCI Lannett Co., Inc. 0.13 -8.0496 Obsessive-Compulsive Disorder Medicine Market by Product Type (NMDA Receptor Blockers, Antipsychotics, Antidepressants), Application (Hospitals, Homecare, Clinics, Others), and Geography – Global Trends & Forecasts to 2019-2029 – Skegness Si - Skegness Siren 11/26/2022, 03:28:57
LCI Lannett Co., Inc. 0.13 -8.0496 Alzheimer's Therapeutics Market Expected to Reach USD 14.20 Billion By 2030 With CAGR 16.2% - Digital Journal 11/22/2022, 06:59:17
LCI Lannett Co., Inc. 0.13 -8.0496 Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday - Arvinas (NASDAQ:ARVN) - Benzinga 11/22/2022, 03:49:19
LCI Lannett Co., Inc. 0.13 -8.0496 Lannett Company, Inc. (LCI) Stock Price Today, Quote & News - Seeking Alpha 11/18/2022, 03:00:00
RMED Ra Medical Systems Inc 0.13 -3.5831 Dynamic cardiac computed tomography characteristics of double-chambered right ventricle Scientific Reports - Nature.com 11/29/2022, 17:04:35
RMED Ra Medical Systems Inc 0.13 -3.5831 Canon doubles down on US presence with new $300M subsidiary - FierceBiotech 11/29/2022, 13:18:55
RMED Ra Medical Systems Inc 0.13 -3.5831 Boston Scientific snatches up gastro-focused Apollo Endosurgery for $615M - FierceBiotech 11/29/2022, 12:54:14
RMED Ra Medical Systems Inc 0.13 -3.5831 Lost focus in the fight vs blindness - Philstar.com 11/29/2022, 11:00:00
RMED Ra Medical Systems Inc 0.13 -3.5831 Philips unveils AI to improve diagnoses from imaging scans - FierceBiotech 11/29/2022, 10:50:33
KDNY Chinook Therapeutics Inc 0.13 0.3467 Proteinuria Therapeutics Market Present Scenario and the Growth Prospects 2022 – 2028 GlaxoSmithKline plc - EIN News 11/29/2022, 07:09:00
KDNY Chinook Therapeutics Inc 0.13 0.3467 Primary Hyperoxaluria Pipeline: Insights into Novel Pipeline Therapies, Key Pharma Companies, Growth Prospects and Future Primary Hyperoxaluria Pipeline Landscape - Digital Journal 11/25/2022, 12:02:57
KDNY Chinook Therapeutics Inc 0.13 0.3467 2022 Polycystic Kidney Disease Drugs in Development Report: Featuring Angion Biomedica, ATLAS Molecular Pharma, Bristol-Myers Squibb and Camurus Among Others - ResearchAndMarkets.com - WV News 11/25/2022, 06:48:39
KDNY Chinook Therapeutics Inc 0.13 0.3467 Chinook Therapeutics to Presen - GuruFocus.com 11/23/2022, 03:02:20
KDNY Chinook Therapeutics Inc 0.13 0.3467 Study estimates the lifetime benefit of combination therapy in patients with kidney disease without diabetes - EurekAlert 11/22/2022, 21:00:43
XNCR Xencor Inc 0.13 1.065 Canon doubles down on US presence with new $300M subsidiary - FierceBiotech 11/29/2022, 13:18:55
XNCR Xencor Inc 0.13 1.065 Boston Scientific snatches up gastro-focused Apollo Endosurgery for $615M - FierceBiotech 11/29/2022, 12:54:14
XNCR Xencor Inc 0.13 1.065 Full-Life wants more, acquires New Jersey biotech in efforts to dominate radiopharmaceutical R&D - FierceBiotech 11/29/2022, 11:14:15
XNCR Xencor Inc 0.13 1.065 Philips unveils AI to improve diagnoses from imaging scans - FierceBiotech 11/29/2022, 10:50:33
XNCR Xencor Inc 0.13 1.065 Almirall signs on for European clinical trial project to collect data for patients - FierceBiotech 11/29/2022, 10:36:01
CRNX Crinetics Pharmaceuticals Inc 0.13 -2.936 Canon doubles down on US presence with new $300M subsidiary - FierceBiotech 11/29/2022, 13:18:55
CRNX Crinetics Pharmaceuticals Inc 0.13 -2.936 Boston Scientific snatches up gastro-focused Apollo Endosurgery for $615M - FierceBiotech 11/29/2022, 12:54:14
CRNX Crinetics Pharmaceuticals Inc 0.13 -2.936 Almirall signs on for European clinical trial project to collect data for patients - FierceBiotech 11/29/2022, 10:36:01
CRNX Crinetics Pharmaceuticals Inc 0.13 -2.936 BigHat, cherry-picking opportunities amid stormy market, pens pact with Merck & Co. - FierceBiotech 11/29/2022, 08:05:06
CRNX Crinetics Pharmaceuticals Inc 0.13 -2.936 Spearing a sphere of MYC proteins could kill cancer cells - FierceBiotech 11/28/2022, 17:34:45
JAZZ Jazz Pharmaceuticals plc 0.13 1.4614 Cannabis Cultivation Global Market Report 2022: Featuring Pacific Cannabis Growers, Atlas Growers, Canntrust Holdings, The Hydropothecary Corporation & Better Holdings - Yahoo Finance 11/29/2022, 05:38:00
JAZZ Jazz Pharmaceuticals plc 0.13 1.4614 Magnetoencephalograph Market to Register Impressive Expansion of USD 393.91 Million with Excellent CAGR Of 4.90% by 2029 - Digital Journal 11/28/2022, 10:50:30
JAZZ Jazz Pharmaceuticals plc 0.13 1.4614 Jazz Pharmaceuticals to Present Data Demonstrating Advancements in Epilepsy Outcomes at the 2022 American Epilepsy Society Annual Meeting Jazz Pharmaceuticals plc - JAZZ's Investor Relations 11/28/2022, 08:18:23
JAZZ Jazz Pharmaceuticals plc 0.13 1.4614 Goldman Sachs, Walmart And These 2 Stocks Insiders Are Selling - Jazz Pharmaceuticals (NASDAQ:JAZZ), Gold - Benzinga 11/28/2022, 07:40:07
JAZZ Jazz Pharmaceuticals plc 0.13 1.4614 Jet Lag Therapy Treatment Market Size – In-depth Analysis Report, Overview, Demand, Top Players, and Current Trends with Forecast to 2028 - Digital Journal 11/28/2022, 05:40:34
SAGE Sage Therapeutics Inc 0.13 1.4768 IntegriChain Distribution Experts to Speak at Informa Trade & Channel Strategies - El Paso Inc. 11/29/2022, 08:28:21
SAGE Sage Therapeutics Inc 0.13 1.4768 Sage Therapeutics, Inc. (NASDAQ:SAGE) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat 11/29/2022, 01:46:05
SAGE Sage Therapeutics Inc 0.13 1.4768 Postpartum Depression Drug Market to Reflect Steady Growth Rate by 2028 Sage Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Cipla Limited. - Digital Journal 11/24/2022, 02:39:21
SAGE Sage Therapeutics Inc 0.13 1.4768 Gene therapy Hemgenix gains FDA clearance for hemophilia B - BioWorld Online 11/23/2022, 13:16:02
SAGE Sage Therapeutics Inc 0.13 1.4768 Alzheimer's Disease Pharmaceutical and Healthcare Latest Pipeline Guide - openPR 11/23/2022, 10:56:00
IONS Ionis Pharmaceuticals Inc 0.13 -3.8681 Relative Strength Alert For Ionis Pharmaceuticals - Nasdaq 11/29/2022, 16:29:00
IONS Ionis Pharmaceuticals Inc 0.13 -3.8681 Is Ionis Pharmaceuticals Inc (IONS) a Good Buy in the Biotechnology Industry? - InvestorsObserver 11/29/2022, 12:39:33
IONS Ionis Pharmaceuticals Inc 0.13 -3.8681 Transcript : Ionis Pharmaceuticals, Inc. Presents at Piper Sandler 34th Annual Healthcare Conference, Nov-29-2022 10:00 AM - Marketscreener.com 11/29/2022, 10:00:00
IONS Ionis Pharmaceuticals Inc 0.13 -3.8681 U.S. Transthyretin Amyloidosis Treatment Market Size will Grow Profitably in upcoming Estimation year 2028 Alnylam Pharmaceuticals, Inc., Pfizer, Inc., Prothena Corporation Plc. - Digital Journal 11/29/2022, 04:30:56
IONS Ionis Pharmaceuticals Inc 0.13 -3.8681 Propulsion of Thalassemia Pipeline as Novel and Extensive 25+ Therapies Likely to Enter in the Treatment Domain DelveInsight - Yahoo Finance 11/28/2022, 13:00:00
BPMC Blueprint Medicines Corp 0.13 3.2501 Mackenzie Financial Corp Raises Position in Blueprint Medicines Co. (NASDAQ:BPMC) - ETF Daily News 11/29/2022, 04:44:21
BPMC Blueprint Medicines Corp 0.13 3.2501 Blueprint Medicines (BPMC) Files Ayvakit sNDA for Indolent SM - Nasdaq 11/23/2022, 10:51:00
BPMC Blueprint Medicines Corp 0.13 3.2501 Blueprint Medicines Co. (NASDAQ:BPMC) Receives Average Rating of "Hold" from Analysts - MarketBeat 11/22/2022, 01:15:09
BPMC Blueprint Medicines Corp 0.13 3.2501 Is Blueprint Medicines Corp (BPMC) Stock a Smart Investment Monday? - InvestorsObserver 11/21/2022, 13:12:27
BPMC Blueprint Medicines Corp 0.13 3.2501 Add Up The Parts: ESGV Could Be Worth $81 - Nasdaq 11/18/2022, 03:00:00
PEN Penumbra Inc 0.13 0.8634 The Global Intracranial Aneurysms Market is Forecasted to Grow at a Significant CAGR of 9.10% by 2027, Assesses DelveInsight - GlobeNewswire 11/29/2022, 13:00:00
PEN Penumbra Inc 0.13 0.8634 Viz.ai and Cercare Medical Partner to Support Neurovascular Clinical Decision Making - Business Wire 11/29/2022, 08:50:00
PEN Penumbra Inc 0.13 0.8634 By 2026, Demand for Global Microcatheters Market Size to Surpass USD 1,800 Million, at a 8.2% CAGR: Industry T - openPR 11/29/2022, 01:28:00
PEN Penumbra Inc 0.13 0.8634 Opportunities for the Global Stroke Rehabilitation Market to reach Blatant Growth in Coming years by 2029 Penumbra, Inc. (REAL System), Saebo Inc, Shanghai Siyi Intelligent Technology Co. - Digital Journal 11/28/2022, 08:44:49
PEN Penumbra Inc 0.13 0.8634 Flow Diverters Market to Hit $1.04 Billion, with CAGR of 15.3% by 2031: Allied Market Research - Yahoo Finance 11/27/2022, 19:07:23
EW Edwards Lifesciences Corp 0.13 -1.2272 Stryker Corp. stock outperforms market despite losses on the day - MarketWatch 11/29/2022, 17:38:00
EW Edwards Lifesciences Corp 0.13 -1.2272 Edwards Lifesciences Corp. stock falls Tuesday, underperforms market - MarketWatch 11/29/2022, 16:58:00
EW Edwards Lifesciences Corp 0.13 -1.2272 After Hours Most Active for Nov 29, 2022 : EW, CRWD, GOOGL, GOOG, AMZN, V, CSX, AAPL, NI, VICI, INFY, MOS - Nasdaq 11/29/2022, 16:29:00
EW Edwards Lifesciences Corp 0.13 -1.2272 Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2022 - Yahoo Finance 11/29/2022, 10:58:00
EW Edwards Lifesciences Corp 0.13 -1.2272 Midmark announces retirement of COO - sidneydailynews.com 11/29/2022, 08:59:37
KYMR Kymera Therapeutics Inc 0.13 3.4394 Captor Therapeutics Reports Q3 2022 Results and Provides Business Update - GlobeNewswire 11/25/2022, 08:00:00
KYMR Kymera Therapeutics Inc 0.13 3.4394 Does Kymera Therapeutics Inc (KYMR) Have What it Takes to be in Your Portfolio Wednesday? - InvestorsObserver 11/23/2022, 15:37:17
KYMR Kymera Therapeutics Inc 0.13 3.4394 Kymera Therapeutics (KYMR) Shares Cross Below 200 DMA - Nasdaq 11/22/2022, 12:52:00
KYMR Kymera Therapeutics Inc 0.13 3.4394 Eczema Therapeutics Market Size to Grow by USD 4.36 Billion, 42% of the Market Growth to Originate from North America - Technavio - PR Newswire 11/22/2022, 11:00:00
KYMR Kymera Therapeutics Inc 0.13 3.4394 Merck Plans To 'Tuck In' Imago And Its Phase III-Ready Hematologic Candidate - Scrip 11/21/2022, 18:03:44
AXSM Axsome Therapeutics Inc 0.13 -5.1913 Company Innovation Scorecard - Ranking 3500 Innovative Companies on Activity, Impact and Disruptive Potential of their Intellectual Property (IP) Portfolio - ResearchAndMarkets.com - Business Wire 11/29/2022, 11:27:00
AXSM Axsome Therapeutics Inc 0.13 -5.1913 Second Recipient Of Eisai/Biogen Alzheimer's Trial Treatment Dies - Kaiser Health News 11/29/2022, 08:54:06
AXSM Axsome Therapeutics Inc 0.13 -5.1913 FedEx To Rally Over 25%? Here Are 10 Other Price Target Changes For Tuesday - CinCor Pharma (NASDAQ:CINC) - Benzinga 11/29/2022, 07:24:15
AXSM Axsome Therapeutics Inc 0.13 -5.1913 Five things for pharma marketers to know: Tuesday, November 29, 2022 - MM+M Online 11/29/2022, 05:01:27
AXSM Axsome Therapeutics Inc 0.13 -5.1913 Tesla, Apple, Anavex, Axsome, Pinduoduo: Why These 5 Stocks Are Drawing Investors' Attention Today - Appl - Benzinga 11/28/2022, 20:02:36
ARWR Arrowhead Pharmaceuticals Inc. 0.13 7.4286 Boston Scientific snatches up gastro-focused Apollo Endosurgery for $615M - FierceBiotech 11/29/2022, 12:54:14
ARWR Arrowhead Pharmaceuticals Inc. 0.13 7.4286 Almirall signs on for European clinical trial project to collect data for patients - FierceBiotech 11/29/2022, 10:36:01
ARWR Arrowhead Pharmaceuticals Inc. 0.13 7.4286 Increasing dental disorders worldwide are expected to proliferate the Dental Implant Abutment Systems Market CAGR: ~7% UnivDatos Market Insights - Yahoo Finance 11/29/2022, 10:30:00
ARWR Arrowhead Pharmaceuticals Inc. 0.13 7.4286 Medicinal Chemistry for Drug Discovery Market to Observe Utmost Growth of USD 12,173.97 Million by 2029, Size, Share, Trends, Key Drivers, Development Trends and Industry Growth Outlook - Yahoo Finance 11/29/2022, 09:30:00
ARWR Arrowhead Pharmaceuticals Inc. 0.13 7.4286 BigHat, cherry-picking opportunities amid stormy market, pens pact with Merck & Co. - FierceBiotech 11/29/2022, 08:05:06
IDXX Idexx Laboratories, Inc. 0.13 2.2269 PerkinElmer Inc. stock falls Tuesday, still outperforms market - MarketWatch 11/29/2022, 17:29:00
IDXX Idexx Laboratories, Inc. 0.13 2.2269 IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch 11/29/2022, 17:08:00
IDXX Idexx Laboratories, Inc. 0.13 2.2269 Henry Schein Inc. stock rises Tuesday, outperforms market - MarketWatch 11/29/2022, 17:07:00
IDXX Idexx Laboratories, Inc. 0.13 2.2269 Companion Animal Diagnostics Market expected to grow at a CAGR of 4.1% by 2027 - openPR 11/29/2022, 07:50:00
IDXX Idexx Laboratories, Inc. 0.13 2.2269 IDEXX Laboratories (NASDAQ:IDXX) Upgraded at TheStreet - MarketBeat 11/29/2022, 07:14:03
TVTX Travere Therapeutics Inc 0.13 -0.1052 Proteinuria Therapeutics Market Present Scenario and the Growth Prospects 2022 – 2028 GlaxoSmithKline plc - EIN News 11/29/2022, 07:09:00
TVTX Travere Therapeutics Inc 0.13 -0.1052 JPMorgan Chase & Co. Grows Position in Travere Therapeutics, Inc. (NASDAQ:TVTX) - Armenian Reporter 11/29/2022, 04:50:13
TVTX Travere Therapeutics Inc 0.13 -0.1052 Head to Head Survey: Minerva Neurosciences (NASDAQ:NERV) and Travere Therapeutics (NASDAQ:TVTX) - ETF Daily News 11/29/2022, 01:18:55
TVTX Travere Therapeutics Inc 0.13 -0.1052 Alport Syndrome Therapeutic Pipeline Analysis, 2022 Insights into the Latest FDA, EMA, and PMDA Approvals, Clinical and Non-Clinical Trials, Emerging Therapies, Treatment Algorithm, and Key Players - Digital Journal 11/28/2022, 21:33:35
TVTX Travere Therapeutics Inc 0.13 -0.1052 Iron Deficiency Day 2022: CSL Vifor calls to take iron seriously - Business Wire India 11/25/2022, 01:37:01
ANGO Angiodynamic Inc 0.13 0 Bone Tumor Ablation Devices Market Will Reflect Significant Growth Prospects By 2028 Medtronic Plc, MedWaves - openPR 11/29/2022, 12:44:00
ANGO Angiodynamic Inc 0.13 0 Dialysis Market To Grow at CAGR 4.7% From 2021 – 2028 Hemodialysis segment holds a dominant position - Digital Journal 11/29/2022, 07:00:40
ANGO Angiodynamic Inc 0.13 0 AngioDynamics, Inc. (NASDAQ:ANGO): Is Breakeven Near? - Simply Wall St 11/29/2022, 05:37:46
ANGO Angiodynamic Inc 0.13 0 Global Sclerotherapy Market Technological Innovations forecast 2022-2030 - EIN News 11/29/2022, 04:25:00
ANGO Angiodynamic Inc 0.13 0 Tip Location Devices Market Benefit and Volume 2022 with Status and Prospect to 2028 Teleflex Incorporated, AngioDynamics Inc., BD, Vygon S.A., - Digital Journal 11/29/2022, 02:02:13
TWST Twist Bioscience Corp 0.13 -1.5575 Transcript : Twist Bioscience Corporation - Special Call - Marketscreener.com 11/29/2022, 12:00:00
TWST Twist Bioscience Corp 0.13 -1.5575 Synthetic Biology Market is anticipated to expand at a CAGR of 19.2% from 2023 to 2032 insightSLIC - PharmiWeb.com 11/29/2022, 10:21:24
TWST Twist Bioscience Corp 0.13 -1.5575 Global NGS Kits Market to Reach $26.05 Billion by 2032 - Exclusive DeepTech M-A-P™ Analysis by BIS Research - Yahoo Finance 11/29/2022, 10:00:00
TWST Twist Bioscience Corp 0.13 -1.5575 North America DNA Digital Data Storage Market to Garner US$ 770.93 Mn by 2028 12.6% CAGR - Impact of COVID-1 - openPR 11/29/2022, 07:58:00
TWST Twist Bioscience Corp 0.13 -1.5575 Global Oligonucleotide Synthesis Global Market Report 2022: Featuring Agilent Technologies, CSBIO, Danaher, Kaneka & More - Yahoo Finance UK 11/29/2022, 04:53:00
CDNA Caredx Inc 0.13 -0.8071 Should You Buy CareDx Inc (CDNA) Stock After it Is Down 4.12% in a Week? - InvestorsObserver 11/28/2022, 14:05:02
CDNA Caredx Inc 0.13 -0.8071 Transplant Diagnostics Market By Product Type, Application, Size and is expected to reach a value of USD 10,13 - openPR 11/27/2022, 23:04:00
CDNA Caredx Inc 0.13 -0.8071 CAREDX, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) - Marketscreener.com 11/23/2022, 16:04:05
CDNA Caredx Inc 0.13 -0.8071 CDNA LAWSUIT ALERT: Levi & Kor - GuruFocus.com 11/22/2022, 12:57:10
CDNA Caredx Inc 0.13 -0.8071 ROSEN, TOP RANKED INVESTOR COU - GuruFocus.com 11/21/2022, 13:55:57
HALO Halozyme Therapeutics Inc. 0.13 1.0271 Hyaluronidase Market Size to reach a revised size of US$ 2390.00 Mn by 2030 CAGR 12.0% - openPR 11/29/2022, 07:46:00
HALO Halozyme Therapeutics Inc. 0.13 1.0271 Halozyme Therapeutics, Inc. (HALO) Stock: How Does it Score on Fundamental Metrics? - InvestorsObserver 11/28/2022, 15:51:02
HALO Halozyme Therapeutics Inc. 0.13 1.0271 SPDR S&P Biotech ETF Experiences Big Outflow - Nasdaq 11/28/2022, 10:47:00
HALO Halozyme Therapeutics Inc. 0.13 1.0271 11 Best Diabetes Stocks To Buy Now - Yahoo Finance 11/27/2022, 17:27:45
HALO Halozyme Therapeutics Inc. 0.13 1.0271 Auto-Injectors Market Is Estimated to Grow At CAGR of 16.60%, 2022-2030 Latest Industry Coverage By Growth Plus Reports - GlobeNewswire 11/24/2022, 02:23:15
BRTX BioRestorative Therapies Inc 0.13 5.4924 Global Allogeneic Stem Cell Therapy Market is expected to grow at a CAGR of 9.85% by 2030 - Digital Journal 11/29/2022, 17:41:58
BRTX BioRestorative Therapies Inc 0.13 5.4924 BioRestorative Therapies to Participate at the RHK Capital Disruptive Growth Conference on Dec. 5-6, 2022 - GlobeNewswire 11/29/2022, 11:20:00
BRTX BioRestorative Therapies Inc 0.13 5.4924 BioRestorative Therapies : BRTX Presentation November 2022 - Marketscreener.com 11/21/2022, 04:29:08
BRTX BioRestorative Therapies Inc 0.13 5.4924 BioRestorative Therapies to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022 - GuruFocus.com 11/16/2022, 09:06:06
BRTX BioRestorative Therapies Inc 0.13 5.4924 Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027 - StreetInsider.com 11/15/2022, 09:35:59
CABA Cabaletta Bio Inc 0.13 8.4507 Will Cabaletta Bio Inc (CABA) Stay at the Top of the Healthcare Sector? - InvestorsObserver 11/29/2022, 13:29:24
CABA Cabaletta Bio Inc 0.13 8.4507 Where Does Cabaletta Bio Inc (CABA) Stock Fall in the Biotechnology Field After It Has Fallen -2.57% This Week? - InvestorsObserver 11/28/2022, 11:51:26
CABA Cabaletta Bio Inc 0.13 8.4507 Cabaletta Bio to Present at th - GuruFocus.com 11/22/2022, 08:08:08
CABA Cabaletta Bio Inc 0.13 8.4507 Cabaletta Bio to Present at the 5th Annual Evercore ISI HealthCONx Conference - The Bakersfield Californian 11/22/2022, 08:02:59
CABA Cabaletta Bio Inc 0.13 8.4507 Is Merck & Co. (MRK) Outperforming Other Medical Stocks This Year? - Nasdaq 11/21/2022, 09:40:00
ZYXI Zynex Inc 0.13 -0.148 Transcutaneous Electrical Nerve Stimulators Market Industry Perspective, Analysis, By Service, Size, Share, Growth, Segment, Trends and Forecast 2028 - Digital Journal 11/29/2022, 04:05:25
ZYXI Zynex Inc 0.13 -0.148 Pelvic Floor Electrical Stimulation Devices Market Size, Development Data, Growth Analysis & Forecast 2022 to 2028 -Utah Medical Products, Inc, Tic Medizintechnik GmbH, Zynex Medical, Atlantic Therapeutics, Verity Medical Ltd, The Prometheus Group - Skegness Siren 11/29/2022, 00:40:01
ZYXI Zynex Inc 0.13 -0.148 Muscle Stimulation Devices Market Huge Growth in Future Scope 2022-2028 DJO Global Inc., Zynex Inc., Neurometrix Inc., R.S. Medical Inc., and Omron Corporation. - Digital Journal 11/28/2022, 07:47:46
ZYXI Zynex Inc 0.13 -0.148 Global Pelvic Floor Electric Stimulator Market Report 2022 to 2027 - Increased Programmes of Collaboration and Partnership in the Pharmaceutical Sector are Driving Growth - ResearchAndMarkets.com - Business Wire 11/28/2022, 07:14:00
ZYXI Zynex Inc 0.13 -0.148 Electrotherapy System Market Revenue Growth Predicted by 2026 Medtronic Plc, Zynex Medical Inc., DJO Global, Inc., Nevro Corporation - Digital Journal 11/28/2022, 02:16:51
MBRX Moleculin Biotech Inc 0.13 9.0909 Celularity, Moleculin Biotech And 2 Other Penny Stocks Insiders Are Aggressively Buying - Celularity (NAS - Benzinga 11/29/2022, 06:11:46
MBRX Moleculin Biotech Inc 0.13 9.0909 Walter V. Klemp Buys 45000 Shares of Moleculin Biotech, Inc. (NASDAQ:MBRX) Stock - ETF Daily News 11/29/2022, 04:58:22
MBRX Moleculin Biotech Inc 0.13 9.0909 Healthcare Stocks Making Moves Tuesday: PALI, BCLI, ACHV, MBRX, QTNT, CFMS, CDIO, ATNM - InvestorsObserver 11/22/2022, 15:02:45
MBRX Moleculin Biotech Inc 0.13 9.0909 Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday - Arvinas (NASDAQ:ARVN) - Benzinga 11/22/2022, 03:49:19
MBRX Moleculin Biotech Inc 0.13 9.0909 WPD Pharmaceuticals : Provides a Corporate Update - Marketscreener.com 11/18/2022, 14:49:10
UBX Unity Biotechnology Inc 0.13 1.5625 Mirum blames enrollment woes for halting phase 2 trial for pregnancy liver disorder - FierceBiotech 11/29/2022, 09:56:03
UBX Unity Biotechnology Inc 0.13 1.5625 Sarepta-partnered Hansa touts new phase 2 data of one-trick pony immunological treatment - FierceBiotech 11/28/2022, 15:35:00
UBX Unity Biotechnology Inc 0.13 1.5625 Gilead, Arcus hope to ease TIGIT anxieties with latest trial data tease - FierceBiotech 11/28/2022, 11:20:00
UBX Unity Biotechnology Inc 0.13 1.5625 Sanofi-backed Escient scores $120M series C for neuro-inflammatory pipeline - FierceBiotech 11/28/2022, 11:12:06
UBX Unity Biotechnology Inc 0.13 1.5625 Eisai, Biogen rocked by 2nd lecanemab death report ahead of Alzheimer's data reveal - FierceBiotech 11/28/2022, 10:53:00
IVA Inventiva - ADR 0.13 5.7692 European ADRs Rise in Monday Trading - InvestorsObserver 11/07/2022, 12:04:03
IVA Inventiva - ADR 0.13 5.7692 FPIs Have Sold Off 29.7 Million Shares, Or 44% Of Their Holdings In Paytm. - Inventiva 11/05/2022, 03:00:00
IVA Inventiva - ADR 0.13 5.7692 European ADRs Move Higher in Friday Trading - Marketscreener.com 11/04/2022, 03:00:00
IVA Inventiva - ADR 0.13 5.7692 Take the Zacks Approach to Beat the Market: Caterpillar, Amgen, Inventiva in Focus - Yahoo Finance 10/31/2022, 03:00:00
IVA Inventiva - ADR 0.13 5.7692 ADANI ENTERPRISE TO RAISE RS 1000CR VIA PUBLIC ISSUE OF DEBENTURES - Inventiva 10/21/2022, 03:00:00
PRTC PureTech Health Plc - ADR 0.13 5.3125 Extremely Robust COVID-19 Clinical Trial Pipeline With 420+ Key Companies Expected to Change the Pace of the COVID-19 Treatment - Yahoo Finance 11/08/2022, 03:00:00
PRTC PureTech Health Plc - ADR 0.13 5.3125 PRTC Stock Forecast, Price & News (PureTech Health) - MarketBeat 11/17/2020, 11:07:24
FONR Fonar Corp. 0.13 0.54 Breast Imaging Market Market is predicted to reach USD 8.02 billion during the forecast period to 2029 - Digital Journal 11/25/2022, 07:05:13
FONR Fonar Corp. 0.13 0.54 FONAR (NASDAQ:FONR) Upgraded to Strong-Buy at StockNews.com - MarketBeat 11/24/2022, 03:13:53
FONR Fonar Corp. 0.13 0.54 Intrauterine Contraceptive Market Booming Worldwide with Latest Trend and Future Scope by 2028 - openPR 11/24/2022, 01:54:00
FONR Fonar Corp. 0.13 0.54 FONAR Corp: Lack Of Equity Premia, Long-Term Reversal Unclear (NASDAQ:FONR) - Seeking Alpha 11/17/2022, 03:00:00
FONR Fonar Corp. 0.13 0.54 FONAR (NASDAQ:FONR) Rating Lowered to Buy at StockNews.com - MarketBeat 11/16/2022, 03:00:00
BPTS Biophytis - ADR 0.13 -10 BPTS Stock Forecast, Price & News (Biophytis) - MarketBeat 02/10/2021, 21:19:51
NBY Novabay Pharmaceuticals Inc 0.13 0.8734 NovaBay Pharmaceuticals Announces the Launch of DERMAdoctor's TikTok Store in China and Expands Online Marketing in the U.S. and China - Business Wire 11/29/2022, 06:50:00
NBY Novabay Pharmaceuticals Inc 0.13 0.8734 Can NovaBay Pharmaceuticals Inc (NBY) Stock Rise to the Top of Healthcare Sector Wednesday? - InvestorsObserver 11/23/2022, 12:09:21
NBY Novabay Pharmaceuticals Inc 0.13 0.8734 North America and Europe Hypochlorous Acid Market is Anticipated to Expand at a CAGR of 4% from 2020 to 2030 - openPR 11/23/2022, 00:17:00
NBY Novabay Pharmaceuticals Inc 0.13 0.8734 Should You Sell NovaBay Pharmaceuticals Inc (NBY) in Biotechnology Industry? - InvestorsObserver 11/22/2022, 12:47:50
NBY Novabay Pharmaceuticals Inc 0.13 0.8734 NOVABAY PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K) - Marketscreener.com 11/18/2022, 16:59:04
PBH Prestige Consumer Healthcare Inc 0.13 0.1986 DDoS as threat to e-commerce. Meta's GDPR fine. TikTok challenge spreads malware. US CYBERCOM's support for Ukraine. - The CyberWire 11/29/2022, 14:14:19
PBH Prestige Consumer Healthcare Inc 0.13 0.1986 Lice Treatment Market Study Providing Information on Top Key Players Bayer, Alliance Pharmaceuticals Ltd, Omega Pharma, Azurity Pharmaceuticals And More - Digital Journal 11/29/2022, 07:36:17
PBH Prestige Consumer Healthcare Inc 0.13 0.1986 Haleon Voted Company Of The Year At The OTC Marketing Awards 2022 - HBW Insight 11/29/2022, 04:54:21
PBH Prestige Consumer Healthcare Inc 0.13 0.1986 10 things to know about global access to healthcare - Philips 11/29/2022, 02:00:00
PBH Prestige Consumer Healthcare Inc 0.13 0.1986 Apple To Buy Manchester United? A Futuristic Buy (NASDAQ:AAPL) - Seeking Alpha 11/28/2022, 09:13:00
CALT Calliditas Therapeutics AB - ADR 0.13 -2.8011 Aurinia (AUPH) Moves 13.1% Higher: Will This Strength Last? - Zacks Investment Research 10/21/2022, 03:00:00
CALT Calliditas Therapeutics AB - ADR 0.13 -2.8011 CALT Stock Forecast, Price & News (Calliditas Therapeutics AB (publ)) - MarketBeat 06/30/2020, 11:53:07
CALT Calliditas Therapeutics AB - ADR 0.13 -2.8011 CALT News Today Why did Calliditas Therapeutics AB (publ) stock go down today? - MarketBeat 06/30/2020, 08:07:35
ANNX Annexon Inc 0.13 -3.3854 Amyotrophic Lateral Sclerosis Clinical Trials, Pipeline Assessment Insights into the Current Therapies, Emer - openPR 11/29/2022, 06:15:00
ANNX Annexon Inc 0.13 -3.3854 New affordable housing groundbreaking at Gladstone School building in Hazelwood - CBS Pittsburgh 11/21/2022, 15:57:00
ANNX Annexon Inc 0.13 -3.3854 We're Keeping An Eye On Annexon's (NASDAQ:ANNX) Cash Burn Rate - Yahoo Finance 11/21/2022, 06:13:02
ANNX Annexon Inc 0.13 -3.3854 Iveric Bio Inc: ISEE Stock's Eye Watering Rise - Value the Markets 11/18/2022, 03:00:00
ANNX Annexon Inc 0.13 -3.3854 Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - Marketscreener.com 11/17/2022, 16:02:02
MTEM Molecular Templates Inc 0.13 -13.4454 Molecular Templates, Inc. to Present Fireside Chats at Two Upcoming Investor Conferences: Evercore ISI's 5th Annual HealthCONx Conference and Piper Sandler's 34th Annual Healthcare Conference - GlobeNewswire 11/23/2022, 16:30:00
MTEM Molecular Templates Inc 0.13 -13.4454 Reactive granulopoiesis depends on T-cell production of IL-17A and neutropenia-associated alteration of gut microbiota Proceedings of the National Academy of Sciences - pnas.org 11/21/2022, 17:20:35
MTEM Molecular Templates Inc 0.13 -13.4454 What Does The Future Hold For Molecular Templates, Inc. (NASDAQ:MTEM)? These Analysts Have Been Cutting Their Estimates - Simply Wall St 11/16/2022, 03:00:00
MTEM Molecular Templates Inc 0.13 -13.4454 7 Dallas-Area Companies Make Deloitte's 2022 Technology Fast 500 List - dallasinnovates.com 11/16/2022, 03:00:00
MTEM Molecular Templates Inc 0.13 -13.4454 Immunogenicity and antigenicity of a conserved fragment of the rhoptry-associated membrane antigen of Plasmodium vivax - Parasites & Vectors - Parasites & Vectors 11/15/2022, 03:00:00
LNSR LENSAR Inc 0.13 -11.9777 LENSAR to Present at Two Upcoming Investor Conferences - Joplin Globe 11/22/2022, 08:02:27
LNSR LENSAR Inc 0.13 -11.9777 Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday - Arvinas (NASDAQ:ARVN) - Benzinga 11/22/2022, 03:49:19
LNSR LENSAR Inc 0.13 -11.9777 Efficacy of a One-Piece Aberration Neutral Hydrophobic Acrylic Toric I OPTH - Dove Medical Press 11/15/2022, 03:00:00
LNSR LENSAR Inc 0.13 -11.9777 LENSAR, Inc. (LNSR) Q3 2022 Earnings Call Transcript - Seeking Alpha 11/12/2022, 03:00:00
LNSR LENSAR Inc 0.13 -11.9777 LENSAR, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) - Marketscreener.com 11/09/2022, 07:35:09
PIRS Pieris Pharmaceuticals Inc 0.13 -1.4554 Pieris Pharmaceuticals, Inc. (PIRS) Stock Price Today, Quote & News - Seeking Alpha 11/25/2022, 03:00:00
PIRS Pieris Pharmaceuticals Inc 0.13 -1.4554 Pieris Pharmaceuticals To Present at Evercore ISI Healthconx Conference - AccessWire 11/23/2022, 08:07:24
PIRS Pieris Pharmaceuticals Inc 0.13 -1.4554 HER2+ Gastric Cancer Pipeline Analysis, 2022 Insights into the Current Therapies, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Clinical Trials, Treatment Outlook, and Key Companies - Digital Journal 11/22/2022, 15:36:31
PIRS Pieris Pharmaceuticals Inc 0.13 -1.4554 Chronic Kidney Disease Drugs Market to Reach US$ 17832.5 Mn with a CAGR value of 4.5% by 2030 Sanofi, AstraZeneca plc., Amgen, Inc., Regeneron Pharmaceuticals, Inc., AbbVie Inc. - Digital Journal 11/11/2022, 03:00:00
PIRS Pieris Pharmaceuticals Inc 0.13 -1.4554 Pieris Pharmaceuticals to Present at Jefferies London Healthcare Conference - AccessWire 11/09/2022, 03:00:00
NURO Neurometrix Inc. 0.13 3.1447 Vagus Nerve Stimulator Market - Top 10 Leading player, Emerging Trends, Region by Forecast to 2026 - EIN News 11/29/2022, 09:00:00
NURO Neurometrix Inc. 0.13 3.1447 Transcutaneous Electrical Nerve Stimulators Market Industry Perspective, Analysis, By Service, Size, Share, Growth, Segment, Trends and Forecast 2028 - Digital Journal 11/29/2022, 04:05:25
NURO Neurometrix Inc. 0.13 3.1447 Muscle Stimulation Devices Market Huge Growth in Future Scope 2022-2028 DJO Global Inc., Zynex Inc., Neurometrix Inc., R.S. Medical Inc., and Omron Corporation. - Digital Journal 11/28/2022, 07:47:46
NURO Neurometrix Inc. 0.13 3.1447 Biogen Inc (BIIB) is lower by 4.23% Monday In Premarket Trading - InvestorsObserver 11/28/2022, 07:10:53
NURO Neurometrix Inc. 0.13 3.1447 Neurometrix Inc (NURO) has fallen 6.25% Monday In Premarket Trading - InvestorsObserver 11/28/2022, 06:55:09
SONN Sonnet BioTherapeutics Holdings Inc 0.13 -3.7624 Do Traders Think Sonnet BioTherapeutics Holdings, Inc. (SONN) Can Turn Around Friday? - InvestorsObserver 11/25/2022, 13:36:54
SONN Sonnet BioTherapeutics Holdings Inc 0.13 -3.7624 GMP Cytokines Market Size to Hit US$ 158.13 Million by 2027 - EIN News 11/22/2022, 01:53:00
SONN Sonnet BioTherapeutics Holdings Inc 0.13 -3.7624 15 Most Volatile Stocks to Buy Now - Yahoo Finance 11/21/2022, 03:00:00
SONN Sonnet BioTherapeutics Holdings Inc 0.13 -3.7624 Should You Hold Sonnet BioTherapeutics Holdings, Inc. (SONN) Stock Monday Morning? - InvestorsObserver 11/14/2022, 09:03:34
SONN Sonnet BioTherapeutics Holdings Inc 0.13 -3.7624 Premarket Mover: Sonnet BioTherapeutics Holdings, Inc. (SONN) Down 7.48% - InvestorsObserver 11/10/2022, 06:48:22
ALPN Alpine Immune Sciences Inc 0.13 -2.6772 Alpine Immune Sciences, Inc. Expected to Post FY2022 Earnings of ($1.58) Per Share (NASDAQ:ALPN) - MarketBeat 11/23/2022, 06:33:25
ALPN Alpine Immune Sciences Inc 0.13 -2.6772 Ancient oral microbiomes support gradual Neolithic dietary shifts towards agriculture - Nature.com 11/22/2022, 11:04:14
ALPN Alpine Immune Sciences Inc 0.13 -2.6772 Alpine Immune Sciences (NASDAQ:ALPN) Now Covered by SVB Leerink - MarketBeat 11/21/2022, 08:34:24
ALPN Alpine Immune Sciences Inc 0.13 -2.6772 Uveitis - Drug Pipeline Landscape, 2022 - openPR 11/17/2022, 03:00:00
ALPN Alpine Immune Sciences Inc 0.13 -2.6772 Alpine Immune Sciences Provides Corporate Update and Reports Third Quarter 2022 Financial Results - Yahoo Finance 11/14/2022, 03:00:00
HTGM HTG Molecular Diagnostics Inc 0.13 4.5455 Cancer & Tumor Profiling and Pathways Market by Product Type (Immunoassays, Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), In-Situ Hybridization (ISH), Microarrays, Mass Spectrometry, Others), Application (Research, Clinic - Skegness Siren 11/25/2022, 14:55:08
HTGM HTG Molecular Diagnostics Inc 0.13 4.5455 The Global miRNA Tools and Services Market size is expected to reach $939.8 million by 2028, rising at a market growth of 17.8% CAGR during the forecast period - Yahoo Finance 11/25/2022, 10:40:00
HTGM HTG Molecular Diagnostics Inc 0.13 4.5455 Immuno Oncology Assays Market Size, Status, and Growth Forecast 2022 to 2030 - openPR 11/23/2022, 04:49:00
HTGM HTG Molecular Diagnostics Inc 0.13 4.5455 Worldwide In Vitro Diagnostic Tests Market Report 2022 with Profiles of 200+ Companies - Financial Results, Product Launches, Company History and Strategic Plans - ResearchAndMarkets.com - Business Wire 11/22/2022, 07:10:00
HTGM HTG Molecular Diagnostics Inc 0.13 4.5455 HTG MOLECULAR DIAGNOSTICS, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - Marketscreener.com 11/18/2022, 16:10:14
PHIO Phio Pharmaceuticals Corp 0.13 6.2484 Korea Warts Therapeutics Market Shares, Strategies, and Forecasts Analysis - openPR 11/15/2022, 03:00:00
PHIO Phio Pharmaceuticals Corp 0.13 6.2484 Incredible Growth Of Rna-Interference (Rnai) Market: Future Trend And Analysis Of Key Segments And Forecast 20 - openPR 11/14/2022, 03:00:00
PHIO Phio Pharmaceuticals Corp 0.13 6.2484 Appointments and advancements for Nov. 11, 2022 - BioWorld Online 11/11/2022, 03:00:00
PHIO Phio Pharmaceuticals Corp 0.13 6.2484 Phio Pharmaceuticals Corp. (PHIO) Reports Q3 Loss, Lags Revenue Estimates - Nasdaq 11/10/2022, 03:00:00
PHIO Phio Pharmaceuticals Corp 0.13 6.2484 Exclusive Report On Rna-Interference (Rnai) Market Size Will Witness Substantial Growth With In-Detailed Competitor Analysis Forecast To 2022-2030 - Digital Journal 11/08/2022, 03:00:00
KZR Kezar Life Sciences Inc 0.13 -2.4324 The Lupus Nephritis Market to Climb Swiftly at a Significant CAGR of 8.4% by 2032 DelveInsight - Digital Journal 11/29/2022, 03:59:44
KZR Kezar Life Sciences Inc 0.13 -2.4324 Pyruvate kinase (PK) deficiency Market is going to hit at a CAGR of 5.20% by 2028 - Digital Journal 11/22/2022, 05:56:36
KZR Kezar Life Sciences Inc 0.13 -2.4324 Polymyositis Pipeline Drugs and Companies Insight Report (2022): Analysis of Clinical Trials, Therapies, Mecha - openPR 11/22/2022, 04:52:00
KZR Kezar Life Sciences Inc 0.13 -2.4324 KZR-540 blocks PD-1 expression and inhibits tumor growth in vivo - BioWorld Online 11/18/2022, 09:00:00
KZR Kezar Life Sciences Inc 0.13 -2.4324 Kezar Life Sciences: Mid-Term Growth Levers Heavily Discounted, Hold (KZR) - Seeking Alpha 11/16/2022, 03:00:00
TRVN Trevena Inc 0.13 -2.3055 Trevena Regains Compliance wit - GuruFocus.com 11/29/2022, 07:03:10
TRVN Trevena Inc 0.13 -2.3055 Trevena Regains Compliance with Nasdaq Listing Requirements - Yahoo Finance 11/29/2022, 07:00:00
TRVN Trevena Inc 0.13 -2.3055 TREVENA INC : Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.com 11/18/2022, 06:04:10
TRVN Trevena Inc 0.13 -2.3055 Marinus Pharmaceuticals Appoints CEO Scott Braunstein, M.D., as Chairman of the Board - Yahoo Finance 11/17/2022, 07:00:00
TRVN Trevena Inc 0.13 -2.3055 Port Authority Focuses on 4th Ward Projects - businessjournaldaily.com 11/16/2022, 13:05:10
BWAY Brainsway Ltd - ADR 0.13 1.0152 BrainsWay Reports Open Market Stock Purchases by Two Board Members - BioSpace 11/28/2022, 07:41:47
BWAY Brainsway Ltd - ADR 0.13 1.0152 Where Will Brainsway ADR Representing 2 Ord Shs (BWAY) Stock Go Next After It Is Lower By 9.38% in a Week? - InvestorsObserver 08/30/2022, 10:07:43
BWAY Brainsway Ltd - ADR 0.13 1.0152 IDEXX (IDXX) to Report Q2 Earnings: What's in the Cards? - Nasdaq 07/26/2022, 03:00:00
MRNA Moderna Inc 0.08 -1.5395 Deal Watch: BMS Backs Out Of UniQure Gene Therapy Collaboration - Scrip 11/29/2022, 18:32:45
MRNA Moderna Inc 0.08 -1.5395 Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch 11/29/2022, 17:32:00
MRNA Moderna Inc 0.08 -1.5395 Moderna Inc. stock falls Tuesday, underperforms market - MarketWatch 11/29/2022, 16:32:00
MRNA Moderna Inc 0.08 -1.5395 What to Watch in the Day Ahead - Wednesday, November 30 - Kalkine Media 11/29/2022, 16:16:32
MRNA Moderna Inc 0.08 -1.5395 Moderna And Pfizer's MRNA Patent Cases Consolidated - Law360 11/29/2022, 14:56:00
AMRN Amarin Corp - ADR 0.07 2.6786 Hopes for Black Friday Boost to Economy Nudge European Equities Higher - InvestorsObserver 11/25/2022, 12:56:43
AMRN Amarin Corp - ADR 0.07 2.6786 Eurozone PMI Data Supports European Equities - InvestorsObserver 11/23/2022, 11:21:52
AMRN Amarin Corp - ADR 0.07 2.6786 European ADRs Continue to Trend Higher in Monday Trading - InvestorsObserver 11/14/2022, 11:08:41
AMRN Amarin Corp - ADR 0.07 2.6786 Premarket Mover: Amarin Corporation plc (AMRN) Down 3.73% - InvestorsObserver 11/14/2022, 07:24:47
AMRN Amarin Corp - ADR 0.07 2.6786 European ADRs Move Lower in Monday Trading - InvestorsObserver 10/31/2022, 12:14:37
EXAS Exact Sciences Corp. 0.07 0.0964 Noteworthy ETF Outflows: ARKK, ZM, ROKU, EXAS - Nasdaq 11/29/2022, 10:56:00
EXAS Exact Sciences Corp. 0.07 0.0964 Why This Biotech Firm is the Top Weight in ARKG - Nasdaq 11/28/2022, 12:42:00
EXAS Exact Sciences Corp. 0.07 0.0964 Insights on the Liquid Biopsy Global Market to 2027 - Extracellular Vesicles Show Promise as Early-Stage Cancer Diagnostic - Yahoo Finance 11/25/2022, 06:08:00
EXAS Exact Sciences Corp. 0.07 0.0964 Breast Cancer Screening Market Expected to Reach at US$ 6209.25 Million by 2027 - EIN News 11/23/2022, 06:59:00
EXAS Exact Sciences Corp. 0.07 0.0964 Vitadx raising $8.3M to roll out system for detecting bladder cancer - BioWorld Online 11/21/2022, 13:00:00
VRAY ViewRay Inc. 0.07 1.3015 ViewRay, Inc. (NASDAQ:VRAY) Director Susan C. Schnabel Acquires 25000 Shares - MarketBeat 11/29/2022, 15:39:09
VRAY ViewRay Inc. 0.07 1.3015 Tuesday 11/29 Insider Buying Report: VRAY, VOXX - Nasdaq 11/29/2022, 13:32:00
VRAY ViewRay Inc. 0.07 1.3015 Radiotherapy Market: Size, Share, Growth, Trends Current Analysis and Forecast (2022-2028) - EIN News 11/28/2022, 12:53:00
VRAY ViewRay Inc. 0.07 1.3015 The Global Radiation Oncology Devices Market to Climb Swiftly at a CAGR of 7.78% by 2027 DelveInsight - Medgadget 11/24/2022, 06:43:33
VRAY ViewRay Inc. 0.07 1.3015 Radiotherapy Market Size, Share, Company Profiles, Emerging Technologies, Landscape and Demand by Forecast to - openPR 11/23/2022, 09:17:00
BNTX BioNTech SE - ADR 0.07 0 Should You Hold Immunic Inc (IMUX) in Biotechnology Industry? - InvestorsObserver 11/29/2022, 11:19:19
BNTX BioNTech SE - ADR 0.07 0 How Will the Market React to BioNTech SE - ADR (BNTX) Stock Getting a Bullish Rating - InvestorsObserver 11/29/2022, 11:06:38
BNTX BioNTech SE - ADR 0.07 0 Weekly Upgrades and Downgrades - InvestorPlace 11/28/2022, 13:46:22
BNTX BioNTech SE - ADR 0.07 0 PFE: 1 High-Dividend Stock to Add to Your Portfolio if You Haven't Already - StockNews.com 11/28/2022, 13:40:30
BNTX BioNTech SE - ADR 0.07 0 Should You Accumulate BioNTech SE - ADR (BNTX) Stock Monday? - InvestorsObserver 11/28/2022, 11:51:26
SRPT Sarepta Therapeutics Inc 0.05 -0.8719 Should You Add Sarepta Therapeutics Inc (SRPT) Stock to Your Portfolio Tuesday? - InvestorsObserver 11/29/2022, 12:48:23
SRPT Sarepta Therapeutics Inc 0.05 -0.8719 Astrazeneca paying up to $320M to acquire individualized TCR T-cell therapy developer Neogene - BioWorld Online 11/29/2022, 12:00:00
SRPT Sarepta Therapeutics Inc 0.05 -0.8719 Notable Monday Option Activity: SRPT, WDAY, CSTM - Nasdaq 11/28/2022, 15:41:00
SRPT Sarepta Therapeutics Inc 0.05 -0.8719 CTLT stock spikes as Barclays says FDA cleared site violations (NYSE:CTLT) - Seeking Alpha 11/28/2022, 14:40:00
SRPT Sarepta Therapeutics Inc 0.05 -0.8719 US STOCKS-Wall St losses limited as Amazon gains on upbeat Cyber Monday - Yahoo Finance 11/28/2022, 10:40:53
NGM Ngm Biopharmaceuticals Inc 0.01 3.071 Insider Buying: NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) Director Purchases 35997 Shares of Stock - MarketBeat 11/23/2022, 18:43:25
NGM Ngm Biopharmaceuticals Inc 0.01 3.071 Metastatic Renal Cell Carcinoma Pipeline Landscape: 40+ Key Players DelveInsight - Digital Journal 11/14/2022, 21:19:16
NGM Ngm Biopharmaceuticals Inc 0.01 3.071 NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat 11/12/2022, 03:00:00
NGM Ngm Biopharmaceuticals Inc 0.01 3.071 Should You Buy NGM Biopharmaceuticals Inc (NGM) Stock on Tuesday? - InvestorsObserver 11/08/2022, 13:00:00
NGM Ngm Biopharmaceuticals Inc 0.01 3.071 Pancreatic Ductal Adenocarcinoma Pipeline Analysis: 80+ Companies are Working to Improve the Treatment Space DelveInsight - Digital Journal 11/08/2022, 03:00:00
LIXT Lixte Biotechnology Holdings Inc 0.01 9.8197 Gaucher Disease Treatment Market Will Have Its Revenue Spiking By 2028 Genzyme Corporation, Pfizer, Inc., Shire Human Genetics Therapies, Inc. - Digital Journal 11/29/2022, 05:54:46
LIXT Lixte Biotechnology Holdings Inc 0.01 9.8197 LIXTE BIOTECHNOLOGY HOLDINGS, INC. : Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.com 11/10/2022, 16:16:44
LIXT Lixte Biotechnology Holdings Inc 0.01 9.8197 Uncleared Midterm Election Result Affects DIS, RBLX, LIXT Stock Price - The Coin Republic 11/10/2022, 03:00:00
LIXT Lixte Biotechnology Holdings Inc 0.01 9.8197 U.S., Europe, and China Myelodysplastic Syndrome (MDS) Treatment Market Size will Grow Profitably in upcoming Estimation year 2028 Onconova Therapeutics, Inc., Acceleron Pharma, Inc., Cipla Limited, Sun Pharmaceutical Industries Limited. - Medgadget 10/18/2022, 03:00:00
LIXT Lixte Biotechnology Holdings Inc 0.01 9.8197 LIXTE BIOTECHNOLOGY ANNOUNCES APPROVAL OF A PHASE 1B/2 - GlobeNewswire 10/13/2022, 03:00:00
APVO Aptevo Therapeutics Inc 0.01 7.6125 Envisagenics Announces Research Collaboration with Bristol Myers Squibb - Investing News Network 11/29/2022, 08:40:59
APVO Aptevo Therapeutics Inc 0.01 7.6125 AMGEN TO WEBCAST INVESTOR CALL AT WCIRDC 2022 - Investing News Network 11/28/2022, 16:50:00
APVO Aptevo Therapeutics Inc 0.01 7.6125 Aptevo Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights - Yahoo Finance 11/10/2022, 03:00:00
APVO Aptevo Therapeutics Inc 0.01 7.6125 Health Canada Approves Camzyos for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy - Investing News Network 11/10/2022, 03:00:00
APVO Aptevo Therapeutics Inc 0.01 7.6125 Alligator Bioscience & Aptevo Therapeutics Announce Publication Highlighting ALG.APV-527 Preclinical Data in Peer-Reviewed Journal Molecular Cancer Therapeutics - Yahoo Finance 11/09/2022, 03:00:00
MTCR Metacrine Inc 0.01 -0.8605 Eisai, Biogen rocked by 2nd lecanemab death report ahead of Alzheimer's data reveal - FierceBiotech 11/28/2022, 10:53:00
MTCR Metacrine Inc 0.01 -0.8605 AstraZeneca beefs up COPD pipeline with $400M biobuck bet on C4X program - FierceBiotech 11/28/2022, 06:44:52
MTCR Metacrine Inc 0.01 -0.8605 The future of Alzheimer's disease research needs solutions that benefit trial patients - FierceBiotech 11/28/2022, 03:00:00
MTCR Metacrine Inc 0.01 -0.8605 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EQ, MTCR, KNBE, IMRA - Marketscreener.com 11/24/2022, 12:18:03
MTCR Metacrine Inc 0.01 -0.8605 SHAREHOLDER ALERT: Weiss Law Investigates Metacrine, Inc. - PR Newswire 11/23/2022, 12:37:00
ARDS Aridis Pharmaceuticals Inc 0.01 -8.5377 Aridis to Participate in Key Opinion Leader Discussion on Immunotherapy for Infectious Diseases - GlobeNewswire 11/22/2022, 09:10:00
ARDS Aridis Pharmaceuticals Inc 0.01 -8.5377 Aridis Pharmaceuticals (ARDS) Reports Q3 Loss, Misses Revenue Estimates - Nasdaq 11/21/2022, 19:55:00
ARDS Aridis Pharmaceuticals Inc 0.01 -8.5377 Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results and Business Update - Yahoo Finance 11/21/2022, 18:30:00
ARDS Aridis Pharmaceuticals Inc 0.01 -8.5377 Will Aridis Pharmaceuticals Inc (ARDS) Outperform the Rest of the Stocks in the Healthcare Sector? - InvestorsObserver 11/17/2022, 11:22:39
ARDS Aridis Pharmaceuticals Inc 0.01 -8.5377 Form NT 10-Q Aridis Pharmaceuticals, For: Sep 30 - StreetInsider.com 11/15/2022, 06:45:44
VCNX Vaccinex Inc 0.01 -6.7432 13 Best Biotech Penny Stocks To Buy Now - Yahoo Finance 11/29/2022, 17:43:35
VCNX Vaccinex Inc 0.01 -6.7432 Cincor slammed over phase II miss with baxdrostat in uncontrolled high blood pressure - BioWorld Online 11/28/2022, 13:43:16
VCNX Vaccinex Inc 0.01 -6.7432 Vaccinex Announces $3.8 Million Private Placement - GlobeNewswire 11/28/2022, 08:00:00
VCNX Vaccinex Inc 0.01 -6.7432 Vaccinex Reports Third Quarter 2022 Results and Provides Corporate Update - Yahoo Finance 11/14/2022, 03:00:00
VCNX Vaccinex Inc 0.01 -6.7432 Vaccinex earnings, Revenue beat in Q3 - Investing.com India 11/14/2022, 03:00:00
HGEN Humanigen Inc 0.01 -1.6835 Stock Performance And Forecast For Humanigen Inc. - Marketing Sentinel 11/29/2022, 08:30:08
HGEN Humanigen Inc 0.01 -1.6835 EQUITY ALERT: Rosen Law Firm E - GuruFocus.com 11/29/2022, 03:44:31
HGEN Humanigen Inc 0.01 -1.6835 Humanigen, Inc. (HGEN) Stock Price Today, Quote & News - Seeking Alpha 11/17/2022, 03:00:00
HGEN Humanigen Inc 0.01 -1.6835 Humanigen Reports Third Quarter 2022 Financial Results - Yahoo Finance 11/14/2022, 03:00:00
HGEN Humanigen Inc 0.01 -1.6835 Humanigen Announces Participation and Presentation at Jefferies London Healthcare Conference - Yahoo Finance 11/10/2022, 03:00:00
JUPW Jupiter Wellness Inc 0.01 -7.6923 Interior Design Services Market 2023-2027: A Descriptive Analysis of Parent Market, Five Forces Model, Market Dynamics, & Segmentation - Technavio - Yahoo Finance 11/28/2022, 11:00:00
JUPW Jupiter Wellness Inc 0.01 -7.6923 Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday By Benzinga - Investing.com UK 11/25/2022, 09:13:00
JUPW Jupiter Wellness Inc 0.01 -7.6923 Healthcare Stocks Making Moves Wednesday: NRBO, NMTC, XGN, GLSI, BIOL, PRE, JUPW, CCCC - InvestorsObserver 11/23/2022, 14:27:27
JUPW Jupiter Wellness Inc 0.01 -7.6923 Regaining NASDAQ Compliance; Jupiter Wellness, Inc. (NASDAQ: JUPW) Bio-Pharma- Wellness Developer with Di - Benzinga 11/22/2022, 10:56:02
JUPW Jupiter Wellness Inc 0.01 -7.6923 JUPITER WELLNESS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Marketscreener.com 11/18/2022, 14:10:05
ISR Isoray, Inc. 0.01 -0.1556 ISORAY, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.com 11/29/2022, 16:29:03
ISR Isoray, Inc. 0.01 -0.1556 Radiotherapy Market 2022 Future Business Opportunities for Business Development Forecasts Up to 2030: Accuray Incorporated, Elekta, Isoray, CIVCO, Hitachi, Ltd., Mevion Medical Systems - Digital Journal 11/29/2022, 05:54:48
ISR Isoray, Inc. 0.01 -0.1556 Radiotherapy Market: Size, Share, Growth, Trends Current Analysis and Forecast (2022-2028) - EIN News 11/28/2022, 12:53:00
ISR Isoray, Inc. 0.01 -0.1556 Veterinary Stereotactic Radiosurgery System Market Report 2022 With Up To 70% Discount On Purchase Includes Demographic Trends, New Developments, Company Performance and Forecast 2029: PetCure Oncology (U.S.), Varian Medical Systems Inc. ( - Digital Journal 11/25/2022, 03:49:04
ISR Isoray, Inc. 0.01 -0.1556 The Global Radiation Oncology Devices Market to Climb Swiftly at a CAGR of 7.78% by 2027 DelveInsight - Medgadget 11/24/2022, 06:43:33
RAPT RAPT Therapeutics Inc 0.01 -6.3867 Atopic Dermatitis Treatment Global Market Report 2022: Focus on Novel Drugs with Novel Mechanisms Presents Opportunities - GlobeNewswire 11/28/2022, 05:18:50
RAPT RAPT Therapeutics Inc 0.01 -6.3867 With More than 150+ Molecules in Various Stages of Development, the Atopic Dermatitis Market to Witness Entry of New Drugs - Market Revenue to Cross USD 11 Billion by 2027 - Arizton - PR Newswire UK 11/22/2022, 12:00:00
RAPT RAPT Therapeutics Inc 0.01 -6.3867 Why RAPT Therapeutics (RAPT) Stock Might be a Great Pick - Nasdaq 11/22/2022, 08:46:00
RAPT RAPT Therapeutics Inc 0.01 -6.3867 Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday - Ambarella (NASDAQ: - Benzinga 11/21/2022, 05:58:38
RAPT RAPT Therapeutics Inc 0.01 -6.3867 Financings for Nov. 18, 2022 - BioWorld Online 11/18/2022, 11:00:00
ECOR ElectroCore Inc 0.01 -2.8096 13 Best Biotech Penny Stocks To Buy Now - Yahoo Finance 11/29/2022, 17:43:35
ECOR ElectroCore Inc 0.01 -2.8096 Vagus Nerve Stimulator Market - Top 10 Leading player, Emerging Trends, Region by Forecast to 2026 - EIN News 11/29/2022, 09:00:00
ECOR ElectroCore Inc 0.01 -2.8096 BARK And 3 Other Stocks Under $2 Insiders Are Aggressively Buying - electroCore (NASDAQ:ECOR), BARK (NYSE - Benzinga 11/28/2022, 08:29:16
ECOR ElectroCore Inc 0.01 -2.8096 Vagus Nerve Stimulation Market Size is projected to reach USD 2,424.01 Million With Growing CAGR of 15% - openPR 11/28/2022, 06:16:00
ECOR ElectroCore Inc 0.01 -2.8096 Cluster Headache Market Size Global Industry Analysis, Statistics & Forecasts to 2032 Zosano Pharma, Eli Lilly and Company, Lundbeck Seattle BioPharmaceutical, Winston Laboratories, GlaxoSmithKline plc - Digital Journal 11/24/2022, 07:16:31
AKTX Akari Therapeutics Plc - ADR 0.01 -6.8621 AKTX Stock Forecast, Price & News (Akari Therapeutics) - MarketBeat 08/11/2016, 19:18:55
TXMD TherapeuticsMD Inc 0.01 13.4752 TherapeuticsMD Inc. stock outperforms market on strong trading day - MarketWatch 11/29/2022, 17:41:00
TXMD TherapeuticsMD Inc 0.01 13.4752 Bio-identical Hormones Market – Porter's Five Forces Strategy Analysis and Forecast 2028 TherapeuticsMD, Inc., BioTE Medical, Defy Medical and SottoPelle. - Digital Journal 11/28/2022, 07:47:46
TXMD TherapeuticsMD Inc 0.01 13.4752 Should You Accumulate TherapeuticsMD Inc (TXMD) Stock Friday? - InvestorsObserver 11/25/2022, 13:36:56
TXMD TherapeuticsMD Inc 0.01 13.4752 TherapeuticsMD Inc. stock falls Friday, underperforms market - MarketWatch 11/18/2022, 03:00:00
TXMD TherapeuticsMD Inc 0.01 13.4752 Bioidentical Hormones Market is Projected to Showcase Significant Growth up to 2029 Noven Pharmaceuticals, Novartis AG, Sottepolle, BioTE Medical, Pfizer Inc., TherapeuticsMD Inc, Bayer AG, Novo Nordisk A/S – The C-Drone Review - The C-Drone Review 11/18/2022, 01:43:53
MEIP MEI Pharma Inc 0.01 -4.1621 ASH: BeiGene deals all-around blow to Imbruvica in CLL - FiercePharma 11/22/2022, 09:00:00
MEIP MEI Pharma Inc 0.01 -4.1621 Kyowa Kirin and MEI Pharma Announce Topline Data from the Phase 2 MIRAGE Study Evaluating Zandelisib in Patients with Indolent B-cell non-Hodgkin's Lymphoma in Japan - Marketscreener.com 11/21/2022, 08:11:08
MEIP MEI Pharma Inc 0.01 -4.1621 Need To Know: Analysts Are Much More Bullish On MEI Pharma, Inc. (NASDAQ:MEIP) - Simply Wall St 11/19/2022, 03:00:00
MEIP MEI Pharma Inc 0.01 -4.1621 The Top 25 Healthcare Technology Leaders of San Diego for 2022 - The Healthcare Technology Report. 11/15/2022, 12:00:00
MEIP MEI Pharma Inc 0.01 -4.1621 MEI Pharma Reports First Quarter Fiscal Year 2023 Results and Operational Highlights - Business Wire 11/14/2022, 03:00:00
NMRD Nemaura Medical Inc 0.01 7.3171 InvestorNewsBreaks – Nemaura Medical Inc.'s (NASDAQ: NMRD) Miboko Pilot Program Kicks Off in UK - StreetInsider.com 11/29/2022, 12:50:00
NMRD Nemaura Medical Inc 0.01 7.3171 Nemaura Commences Pilot Program of Miboko with the NHS in the United Kingdom - The Bakersfield Californian 11/29/2022, 08:02:25
NMRD Nemaura Medical Inc 0.01 7.3171 Non-invasive Biosensors Market Evaluation With Focus On development & Trends 2022 – 2028 Nemaura Medical, Inc., MediWise Ltd., Integrity Applications Inc. - Digital Journal 11/25/2022, 04:51:44
NMRD Nemaura Medical Inc 0.01 7.3171 Non-Invasive Blood Glucose Monitoring Devices Market Growth in Future Scope 2022-2028 DiaMonTech GmbH - EIN News 11/22/2022, 06:55:00
NMRD Nemaura Medical Inc 0.01 7.3171 Global Wearable Electronic Skin Patches Market Report 2023: Analysis of Electronic Skin Patches for Disease Prevention, Clinical Trials and Chronic Disease Management - PR Newswire 11/22/2022, 06:00:00
CYCC Cyclacel Pharmaceuticals Inc 0.01 -2.5434 Abbott Receives Three CES 2023 Innovation Awards for Advancements in Health Technology - Investing News Network 11/17/2022, 09:35:04
CYCC Cyclacel Pharmaceuticals Inc 0.01 -2.5434 After nearly 20 years, Cyclacel kicks phase 3 leukemia drug back to Daiichi - FierceBiotech 11/10/2022, 10:14:27
CYCC Cyclacel Pharmaceuticals Inc 0.01 -2.5434 CYCLACEL PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Marketscreener.com 11/10/2022, 03:00:00
CYCC Cyclacel Pharmaceuticals Inc 0.01 -2.5434 Cyclacel Pharmaceuticals, Inc. (CYCC) Q3 2022 Earnings Call Transcript - Seeking Alpha 11/09/2022, 03:00:00
CYCC Cyclacel Pharmaceuticals Inc 0.01 -2.5434 Cyclacel Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update - Yahoo Finance 11/09/2022, 03:00:00
IBIO iBio Inc 0.01 1.3423 iBio Inc. stock rises Tuesday, outperforms market - MarketWatch 11/29/2022, 17:07:00
IBIO iBio Inc 0.01 1.3423 Plant-based Expression Systems Market to Record an Exponential CAGR by 2030 - Exclusive Report by InsightAce Analytic - Yahoo Finance 11/29/2022, 04:15:00
IBIO iBio Inc 0.01 1.3423 Plant Based Biologics Market Projected to Grow at a CAGR of 3.4 % throughout 2022 – 2030 - Digital Journal 11/28/2022, 03:41:55
IBIO iBio Inc 0.01 1.3423 Plant-Based Vaccines Market Future Developments, Business Insights, End Users, Application And Forecast To 2028 Medicago, Inc., IBIO, Inc., Icon Genetics GmbH, Lumen Bioscience, - Digital Journal 11/23/2022, 07:06:05
IBIO iBio Inc 0.01 1.3423 iBio Inc. stock underperforms Tuesday when compared to competitors - MarketWatch 11/22/2022, 17:00:00
MBOT Microbot Medical Inc 0.01 5.5172 10 Best Robotic Stocks Under $10 - Yahoo Finance 11/21/2022, 15:04:40
MBOT Microbot Medical Inc 0.01 5.5172 Microbot Medical Announces New Webinar Series to Engage Stakeholders with Experts in the Healthcare Space - Yahoo Finance 11/15/2022, 03:00:00
MBOT Microbot Medical Inc 0.01 5.5172 Next-Generation Surgical Robotics Market By 2022: Size, Business Improvement, Offer and Valuable - The Knox Reports 11/06/2022, 02:00:00
MBOT Microbot Medical Inc 0.01 5.5172 Microbot Medical Receives Additional Patent Allowance in Israel for the LIBERTY® Robotic System - GlobeNewswire 11/03/2022, 03:00:00
MBOT Microbot Medical Inc 0.01 5.5172 Microbot Medical Adds the Head of the Interventional Radiology Unit of Europe's Largest Cancer Center, Dr. Thierry Jacques De Baère to its Scientific Advisory Board - GlobeNewswire 10/31/2022, 03:00:00
AWH Aspira Women`s Health Inc 0.01 9.375 Aspira Women's Health Announces the Commercial Launch of - GlobeNewswire 11/29/2022, 16:01:00
AWH Aspira Women`s Health Inc 0.01 9.375 Sienna Senior Living Inc. (LWSCF) Q3 2022 Earnings Call Transcript - Seeking Alpha 11/12/2022, 03:00:00
AWH Aspira Women`s Health Inc 0.01 9.375 Aspira: Q3 Earnings Snapshot - Macon Telegraph 11/11/2022, 03:00:00
AWH Aspira Women`s Health Inc 0.01 9.375 Aspira Women's Health Reports Third Quarter 2022 Financial - GlobeNewswire 11/10/2022, 03:00:00
AWH Aspira Women`s Health Inc 0.01 9.375 Aspira Women's Health Inc. (AWH) Q3 2022 Earnings Call Transcript - Seeking Alpha 11/10/2022, 03:00:00
ASLN ASLAN Pharmaceuticals Ltd - ADR 0.01 -10.3863 China COVID Deaths Rattle Asian Equities - Marketscreener.com 11/21/2022, 10:42:01
ASLN ASLAN Pharmaceuticals Ltd - ADR 0.01 -10.3863 Asian Equities Diverge From US Markets, Climb in Thursday Trading - Marketscreener.com 11/17/2022, 03:00:00
ASLN ASLAN Pharmaceuticals Ltd - ADR 0.01 -10.3863 Asian ADRs Rebound Modestly After Slow Start to Monday Trading - InvestorsObserver 11/14/2022, 10:59:02
ASLN ASLAN Pharmaceuticals Ltd - ADR 0.01 -10.3863 Asian ADRs Struggle to Claw Back into Positive Territory MarketScreener - Marketscreener.com 11/03/2022, 03:00:00
ASLN ASLAN Pharmaceuticals Ltd - ADR 0.01 -10.3863 ASLAN (ASLN) Starts Phase IIb Study in Atopic Dermatitis - Nasdaq 01/21/2022, 03:00:00
OCUP Ocuphire Pharma Inc 0.01 5.3872 Glaucoma Pipeline Assessment 70+ Companies & 70+ Drugs DelveInsight - Digital Journal 11/29/2022, 16:16:47
OCUP Ocuphire Pharma Inc 0.01 5.3872 Ocular Hypertension Therapeutic Pipeline Analysis, 2022 In-depth Insights into the Latest FDA, EMA, and PMDA - openPR 11/28/2022, 04:31:00
OCUP Ocuphire Pharma Inc 0.01 5.3872 2022-11-21 NDAQ:OCUP Press Release Ocuphire Pharma Inc. - Stockhouse 11/21/2022, 08:06:39
OCUP Ocuphire Pharma Inc 0.01 5.3872 Ocuphire to Present at Five Up - GuruFocus.com 11/21/2022, 08:02:08
OCUP Ocuphire Pharma Inc 0.01 5.3872 Other news to note for Nov. 15, 2022 - BioWorld Online 11/15/2022, 03:00:00
MGTA Magenta Therapeutics Inc 0.01 -8.7719 Sarepta-partnered Hansa touts new phase 2 data of one-trick pony immunological treatment - FierceBiotech 11/28/2022, 15:35:00
MGTA Magenta Therapeutics Inc 0.01 -8.7719 Sanofi-backed Escient scores $120M series C for neuro-inflammatory pipeline - FierceBiotech 11/28/2022, 11:12:06
MGTA Magenta Therapeutics Inc 0.01 -8.7719 Eisai, Biogen rocked by 2nd lecanemab death report ahead of Alzheimer's data reveal - FierceBiotech 11/28/2022, 10:57:27
MGTA Magenta Therapeutics Inc 0.01 -8.7719 AstraZeneca beefs up COPD pipeline with $400M biobuck bet on C4X program - FierceBiotech 11/28/2022, 06:44:52
MGTA Magenta Therapeutics Inc 0.01 -8.7719 The future of Alzheimer's disease research needs solutions that benefit trial patients - FierceBiotech 11/28/2022, 03:00:00
SEEL Seelos Therapeutics Inc 0.01 -4.1611 COMPASS Pathways to participate in upcoming Evercore ISI HealthCONx Conference - Investing News Network 11/28/2022, 16:28:22
SEEL Seelos Therapeutics Inc 0.01 -4.1611 Albert Labs Announces Private Placement - Investing News Network 11/25/2022, 09:37:23
SEEL Seelos Therapeutics Inc 0.01 -4.1611 SEELOS THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - Marketscreener.com 11/23/2022, 16:06:08
SEEL Seelos Therapeutics Inc 0.01 -4.1611 Seelos Therapeutics to Hold a Research and Development Update Conference Call and Webcast on December 15, 2022 - PR Newswire 11/23/2022, 08:00:00
SEEL Seelos Therapeutics Inc 0.01 -4.1611 Nirvana Life Sciences Inc. announces agreement to acquire the licensed distributor of a Patented, WHO approved, herbal treatment for opiate addiction - Investing News Network 11/21/2022, 09:35:32
PFE Pfizer Inc. 0.01 -0.3026 13 Best Biotech Penny Stocks To Buy Now - Yahoo Finance 11/29/2022, 17:43:35
PFE Pfizer Inc. 0.01 -0.3026 TherapeuticsMD Inc. stock outperforms market on strong trading day - MarketWatch 11/29/2022, 17:41:00
PFE Pfizer Inc. 0.01 -0.3026 Pfizer Inc. stock outperforms competitors despite losses on the day - MarketWatch 11/29/2022, 17:27:00
PFE Pfizer Inc. 0.01 -0.3026 Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch 11/29/2022, 17:24:00
PFE Pfizer Inc. 0.01 -0.3026 Merck & Co. Inc. stock rises Tuesday, outperforms market - MarketWatch 11/29/2022, 17:20:00